11(1):1. doi: 10.1038/s41387-020-00147-8.","Boscari F","Nutr Diabetes","2021","2021/01/08","PMC7790327","","10.1038/s41387-020-00147-8"

9(1):e001858. doi: 10.1136/bmjdrc-2020-001858.","Izzi-Engbeaya C","BMJ Open Diabetes Res Care","2021","2021/01/07","PMC7789097","","10.1136/bmjdrc-2020-001858"

14(6):2245-2249. doi: 10.1016/j.dsx.2020.11.007. Epub 2020 Nov 17.","Soni M","Diabetes Metab Syndr","2020","2021/01/05","PMC7670909","","10.1016/j.dsx.2020.11.007"

14(6):2241-2243. doi: 10.1016/j.dsx.2020.11.013. Epub 2020 Nov 20.","Highton PJ","Diabetes Metab Syndr","2020","2021/01/05","PMC7677038","","10.1016/j.dsx.2020.11.013"

14(6):2219-2230. doi: 10.1016/j.dsx.2020.11.011. Epub 2020 Nov 17.","Yonas E","Diabetes Metab Syndr","2020","2021/01/05","PMC7669483","","10.1016/j.dsx.2020.11.011"

14(6):2211-2217. doi: 10.1016/j.dsx.2020.11.012. Epub 2020 Nov 17.","Boddu SK","Diabetes Metab Syndr","2020","2021/01/05","PMC7669477","","10.1016/j.dsx.2020.11.012"

14(6):2199-2203. doi: 10.1016/j.dsx.2020.11.001. Epub 2020 Nov 11.","Jayawardena R","Diabetes Metab Syndr","2020","2021/01/05","PMC7656158","","10.1016/j.dsx.2020.11.001"

14(6):2177-2183. doi: 10.1016/j.dsx.2020.11.006. Epub 2020 Nov 11.","Lukito AA","Diabetes Metab Syndr","2020","2021/01/05","PMC7657016","","10.1016/j.dsx.2020.11.006"

44:737-46)","Moon SJ, Rhee EJ, Lee WY, Yoon KH.","Diabetes Metab J. 2020 Dec

44(6):942-943. doi: 10.4093/dmj.2020.0266. Epub 2020 Dec 23.","Moon SJ","Diabetes Metab J","2020","2021/01/04","","","10.4093/dmj.2020.0266"

44:737-46)","Kim K, Oh TJ.","Diabetes Metab J. 2020 Dec

44(6):938-939. doi: 10.4093/dmj.2020.0236. Epub 2020 Dec 23.","Kim K","Diabetes Metab J","2020","2021/01/04","","","10.4093/dmj.2020.0236"

44(6):897-907. doi: 10.4093/dmj.2020.0199. Epub 2020 Dec 23.","Chun SY","Diabetes Metab J","2020","2021/01/04","","","10.4093/dmj.2020.0199"

Critical COVID-19 France Investigators.","Diabetes Metab. 2020 Dec 31:101222. doi: 10.1016/j.diabet.2020.101222. Online ahead of print.","Sutter W","Diabetes Metab","2020","2021/01/03","PMC7774010","","10.1016/j.diabet.2020.101222"

Marked hyperglycemia and ketosis in a non-obese patient with new onset diabetes and very mild COVID-19 symptoms: A case report

Ghosh A, Misra A.

Health literacy, preventive COVID 19 behaviour and adherence to chronic disease treatment during lockdown among patients registered at primary health facility in urban Jodhpur, Rajasthan

Gautam V, S D, Rustagi N, Mittal A, Patel M, Shafi S, Thirunavukkarasu P, Raghav P.

Reply to letter to the editor: "COVID-19 and the endocrine system: exploring the unexplored". Focus on acromegaly

Banerjee M, Pal R.

Impaired anti-SARS-CoV-2 antibody response in non-severe COVID-19 patients with diabetes mellitus: A preliminary report

Pal R, Sachdeva N, Mukherjee S, Suri V, Zohmangaihi D, Ram S, Puri GD, Bhalla A, Soni SL, Pandey N, Bhansali A, Bhadada SK.

Diabetic patients with COVID-19 need more attention and better glycemic control

Xu M, Yang W, Huang T, Zhou J.

SARS-CoV-2 Infection Presenting with Hyperglycemia and Ketosis: A Case Series of Three Diabetic Patients

Kayina CA, Maitra S, Anand RK, Ray BR, Baidya DK, Subramaniam R.

Urine abnormalities predict acute kidney injury in COVID-19 patients: An analysis of 110 cases in Chennai, South India

Sundaram S, Soni M, Annigeri R.

The risk factors for mortality of diabetic patients with severe COVID-19: A retrospective study of 167 severe COVID-19 cases in Wuhan

Hui Y, Li Y, Tong X, Wang Z, Mao X, Huang L, Zhang D.

Clinical Features and Risk Factors of ICU Admission for COVID-19 Patients with Diabetes

Lei M, Lin K, Pi Y, Huang X, Fan L, Huang J, Liu R, Liu L, Shao X, Hu K, Yang L, Qin S, He F.

Sleep-wake cycle impairment adding on the risk for COVID-19 severity in people with diabetes

Barone MTU, Ngongo B, Menna-Barreto L.

Hypertension, Diabetes and Obesity, Major Risk Factors for Death in Patients With COVID-19 in Mexico

Peña JE, Rascón-Pacheco RA, Ascencio-Montiel IJ, González-Figueroa E, Fernández-Gárate JE, Medina-Gómez OS, Borja-Bustamante P, Santillán-Oropeza JA, Borja-Aburto VH.

CT-based staging and prognosis of novel coronavirus (COVID-19) pneumonia: correlation with blood glucose levels

Xu CC, Ruan XZ, Chen XQ, Huang QL, Zhao ZY, Ru L.

An overview of COVID-19 in people with diabetes pathophysiology and considerations in the inpatient setting

Fleming N, Sacks LJ, Pham C, Neoh SL, Ekinci E.

Differences in the Clinical and Hematological Characteristics of COVID-19 Patients with and without Type 2 Diabetes

Sun Y, Zhao R, Hu Z, Wang W, Wang S, Gao L, Fei J, Jian X, Li Y, Zheng H, Hou X, Chen L.

Association of Daily Home-Based Hot Water Bathing and Glycemic Control in Ambulatory Japanese Patients with Type 2 Diabetes Mellitus During the COVID-19 Pandemic: A Multicenter Cross-Sectional Study

Kamioka H, Mori Y, Horiuchi T, Hayashi T, Ohmura K, Yamaguchi S, Kato M.

Independent and combined effects of hypertension and diabetes on clinical outcomes in patients with COVID-19: A retrospective cohort study of Huoshen Mountain Hospital and Guanggu Fangcang Shelter Hospital

Sun Y, Guan X, Jia L, Xing N, Cheng L, Liu B, Zhang S, He K.

The influence of diabetes and hypertension on outcome in COVID-19 patients: Do we mix apples and oranges?

Tadic M, Cuspidi C.

New-Onset Diabetes in COVID-19: Time to Frame Its Fearful Symmetry

Papachristou S, Stamatiou I, Stoian AP, Papanas N.

Mapping of type 2 diabetes proteins to COVID-19 biomarkers: A proteomic analysis

Moin ASM, Al-Qaissi A, Sathyapalan T, Atkin SL, Butler AE.

Death due to COVID-19 in a patient with diabetes, epilepsy, and gout comorbidities

Safdarian AR, Momenzadeh K, Kahe F, Farhangnia P, Rezaei N.

Pathophysiology of SARS-CoV-2 in Lung of Diabetic Patients

Oliveira TL, Melo IS, Cardoso-Sousa L, Santos IA, El Zoghbi MB, Shimoura CG, Georjutti RP, Castro OW, Goulart LR, Jardim ACG, Cunha TM, Sabino-Silva R.

Stay-at-Home Orders During the COVID-19 Pandemic, an Opportunity to Improve Glucose Control Through Behavioral Changes in Type 1 Diabetes

Potier L, Hansel B, Larger E, Gautier JF, Carreira D, Assemien R, Lantieri O, Riveline JP, Roussel R.

Continuous Glucose Monitoring in the Intensive Care Unit During the COVID-19 Pandemic

Agarwal S, Mathew J, Davis GM, Shephardson A, Levine A, Louard R, Urrutia A, Perez-Guzman C, Umpierrez GE, Peng L, Pasquel FJ.

High prevalence of diabetes and other comorbidities in hospitalized patients with COVID-19 in Delhi, India, and their association with outcomes

Mithal A, Jevalikar G, Sharma R, Singh A, Farooqui KJ, Mahendru S, Krishnamurthy A, Dewan A, Budhiraja S.

COVID-19 pandemic: can fasting plasma glucose and HbA1c replace the oral glucose tolerance test to screen for hyperglycaemia in pregnancy?

Nachtergaele C, Vicaut E, Pinto S, Tatulashvili S, Bihan H, Sal M, Berkane N, Allard L, Baudry C, Carbillon L, Cosson E.

Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland

McGurnaghan SJ, Weir A, Bishop J, Kennedy S, Blackbourn LAK, McAllister DA, Hutchinson S, Caparrotta TM, Mellor J, Jeyam A, O'Reilly JE, Wild SH, Hatam S, Höhn A, Colombo M, Robertson C, Lone N, Murray J, Butterly E, Petrie J, Kennon B, McCrimmon R, Lindsay R, Pearson E, Sattar N, McKnight J, Philip S, Collier A, McMenamin J, Smith-Palmer A, Goldberg D, McKeigue PM, Colhoun HM; Public Health Scotland COVID-19 Health Protection Study Group; Scottish Diabetes Research Network Epidemiology Group.

Observational research on severe COVID-19 in diabetes

Stehouwer CDA.

Tele-medicine versus face-to-face consultation in Endocrine Outpatients Clinic during COVID-19 outbreak: a single-center experience during the lockdown period

Ceccato F, Voltan G, Sabbadin C, Camozzi V, Merante Boschin I, Mian C, Zanotto V, Donato D, Bordignon G, Capizzi A, Carretta G, Scaroni C.

Bilateral retinal vein occlusion and diabetic retinopathy after COVID-19

Rego Lorca D, Rouco Fernandez A, Jimenez Santos M, Saenz-Frances F, Burgos-Blasco B, Donate Lopez J.

Non-insulin anti-diabetic agents in patients with type 2 diabetes and COVID-19: A Critical Appraisal of Literature

Singh AK, Singh R, Saboo B, Misra A.

Clinical characteristics and short-term prognosis of in-patients with diabetes and COVID-19: A retrospective study from an academic center in Belgium

Orioli L, Servais T, Belkhir L, Laterre PF, Thissen JP, Vandeleene B, Maiter D, Yombi JC, Hermans MP.

Is newly diagnosed diabetes as frequent as preexisting diabetes in COVID-19 patients?

Sathish T, Cao Y.

Type 2 Diabetes and viral infection; cause and effect of disease

Turk Wensveen T, Gašparini D, Rahelić D, Wensveen FM.

[Screening for gestational diabetes due to of the COVID-19 pandemic]

Torosyan AO, Loginova EV, Gagaev CG.

[Diabetes and COVID-19: analysis of the clinical outcomes according to the data of the russian diabetes registry]

Shestakova MV, Vikulova OK, Isakov MА, Dedov II.

Determinants of Mental Health Outcomes Among People With and Without Diabetes During the COVID-19 Outbreak in the Arab Gulf Region

Al-Sofiani ME, Albunyan S, Alguwaihes AM, Kalyani RR, Golden SH, Alfadda A.

Paediatric diabetes care during the COVID-19 pandemic: Lessons learned in scaling up telemedicine services

March CA, Flint A, DeArment D, Gilliland A, Kelly K, Rizzitano E, Chrisman A, Muzumdar RH, Libman IM.

Widespread sensory neuropathy in diabetic patients hospitalized with severe COVID-19 infection

Odriozola A, Ortega L, Martinez L, Odriozola S, Torrens A, Corroleu D, Martínez S, Ponce M, Meije Y, Presas M, Duarte A, Belén Odriozola M, Malik RA.

Long COVID-19: Challenges in the diagnosis and proposed diagnostic criteria

Raveendran AV.

Comparison of Mortality Rate and Severity of Pulmonary Involvement in Coronavirus Disease-2019 Adults Patients With and Without Type 2 Diabetes: A Cohort Study

Khalili S, Moradi O, Kharazmi AB, Raoufi M, Sistanizad M, Shariat M.

Impact of COVID-19 pandemic and diabetes on mechanical reperfusion in patients with STEMI: insights from the ISACS STEMI COVID 19 Registry

De Luca G, Cercek M, Jensen LO, Vavlukis M, Calmac L, Johnson T, Roura I Ferrer G, Ganyukov V, Wojakowski W, von Birgelen C, Versaci F, Ten Berg J, Laine M, Dirksen M, Casella G, Kala P, Díez Gil JL, Becerra V, De Simone C, Carrill X, Scoccia A, Lux A, Kovarnik T, Davlouros P, Gabrielli G, Flores Rios X, Bakraceski N, Levesque S, Guiducci V, Kidawa M, Marinucci L, Zilio F, Galasso G, Fabris E, Menichelli M, Manzo S, Caiazzo G, Moreu J, Sanchis Forés J, Donazzan L, Vignali L, Teles R, Bosa Ojed

Downregulation of microRNA-146a in diabetes, obesity and hypertension may contribute to severe COVID-19

Roganović J.

Psychological impact of COVID-19 pandemic on chronic disease patients in Dessie town government and private hospitals, Northeast Ethiopia

Addis SG, Nega AD, Miretu DG.

A recalcitrant post-amputative diabetic foot ulcer treated with a new mechanical debridement system during COVID-19 lockdown

Vermigli C, Ceppitelli C, Lupattelli R, Eugeni E, Murdolo G.

microRNA-146a and -155, upregulated by periodontitis and type 2 diabetes in oral fluids, are predicted to regulate SARS-CoV-2 oral receptors genes

Roganović JR.

Impact of Diabetes in Patients Diagnosed With COVID-19

Abu-Farha M, Al-Mulla F, Thanaraj TA, Kavalakatt S, Ali H, Abdul Ghani M, Abubaker J.

Comparison of Diabetic Ketoacidosis in Adults During the SARS-CoV-2 Outbreak and Over the Same Time Period for the Preceding 3 Years

Misra S, Khozoee B, Huang J, Mitsaki K, Reddy M, Salem V, Tan T, Tharakan G, Gable D, Bravis V, Valabhji J.

A Review of the Current Status of Gestational Diabetes Mellitus in Australia-The Clinical Impact of Changing Population Demographics and Diagnostic Criteria on Prevalence

Laurie JG, McIntyre HD.

Is metformin a miracle or a menace in COVID-19 patients with type 2 diabetes?

Lui DTW, Tan KCB.

Pre-Existing Cytokine and NLRP3 Inflammasome Activation and Increased Vascular Permeability in Diabetes: A Possible Fatal Link With Worst COVID-19 Infection Outcomes?

Lambadiari V, Kousathana F, Raptis A, Katogiannis K, Kokkinos A, Ikonomidis I.

Ramadan fasting in people with type 1 diabetes during COVID-19 pandemic: The DaR Global survey

Hassanein M, Alamoudi RM, Kallash MA, Aljohani NJ, Alfadhli EM, El Tony L, Khogeer GS, Alfadhly AF, ElMamoon Khater A, Yakoob Ahmedani M, Akif Buyukbese M, Shaltout I, Belkhadir J, Hafidh K, Chowdhury TA, Hussein Z, Samir Elbarbary N.

Evaluation of severe hypoglycemia and common mental disorders in patients receiving insulin analogues for treatment of type 1 diabetes

Berlanda G, Telo GH, Krug BC, Scheffel RS, Pasinato B, Iorra F, Dos Reis JG, Picon PD, Schaan BD.

Change in glucose-lowering medication regimen in individuals with type 2 diabetes mellitus during the COVID-19 pandemic in Germany

Jacob L, Rickwood S, Rathmann W, Kostev K.

Self care practices and psychological distress among diabetic patients in Manipur during COVID-19: A scenario from the North East

Bala R, Srivastava A, Potsangbam T, Anal L, Ningthoujam GD.

Hospital care: improving outcomes in type 1 diabetes

Boeder S, Kulasa K.

The Impact of the COVID-19 Pandemic on People with Diabetes and Diabetes Services: A pan-European Survey of Diabetes Specialist Nurses undertaken by the Foundation of European Nurses in Diabetes survey consortium

Forde R, Arente L, Ausili D, De Backer K, Due-Christensen M, Epps A, Fitzpatrick A, Grixti M, Groen S, Halkoaho A, Huber C, Iversen MM, Johansson UB, Leippert C, Ozcan S, Parker J, Paiva AC, Sanpetreanu A, Savet MA, Rosana SC, Szewczyk A, Valverde M, Vlachou E, Forbes A; FEND COVID-19 consortium.

Lung and Kidney ACE2 and TMPRSS2 in Renin Angiotensin System Blocker Treated Comorbid Diabetic Mice Mimicking Host Factors That Have Been Linked to Severe COVID-19

Batchu SN, Kaur H, Yerra VG, Advani SL, Kabir MG, Liu Y, Klein T, Advani A.

Are health care workers following preventive practices in the COVID-19 pandemic properly? - A cross-sectional survey from India

Agarwal A, Ranjan P, Saraswat A, Kasi K, Bharadiya V, Vikram N, Singh A, Upadhyay AD, Baitha U, Klanidhi KB, Chakrawarty A.

Managing Type 1 Diabetes among Saudi adults on insulin pump therapy during the COVID-19 lockdown

Magliah SF, Zarif HA, Althubaiti A, Sabban MF.

Cardiometabolic vigilance in COVID-19 and resource husbandry in resource-challenged times: Clinical practice- based expert opinion

Das AK, Kalra S, B K, Sharma K, John M, Nair T, Shaikh S, Khandelwal D, Priya G, Dutta D, Gangadhar P, Dhingra A, Tiwaskar M, Shukla R, Das S, Baruah MP, Gangopadhyay KK, Ramakrishnan S, Deshmukh V, Dasgupta A, Kumar G, Pandey N, Joshi A, Surana VK, Punyani H, Shah P, Rattan A, Chandrasekaran S, Asirwatham A.

Management of patients with diabetes and obesity in the COVID-19 era: experiences and learnings from South and East Europe, the Middle East, and Africa

Giorgino F, Bhana S, Czupryniak L, Dagdelen S, Galstyan GR, Janež A, Lalić N, Nouri N, Rahelić D, Pantea Stoian A, Raz I.

Association of metformin with mortality or ARDS in patients with COVID-19 and type 2 diabetes: a retrospective cohort study

Jiang N, Chen Z, Yin X, Liu L, Yang H, Tan X, Wang J, Li H, Tian M, Lu Z, Xiong N, Gong Y.

High admission blood glucose independently predicts poor prognosis in COVID-19 patients: A systematic review and dose-response meta-analysis

Lazarus G, Audrey J, Kharisma Wangsaputra V, Tamara A, Tahapary DL.

Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19

Lalau JD, Al-Salameh A, Hadjadj S, Goronflot T, Wiernsperger N, Pichelin M, Allix I, Amadou C, Bourron O, Duriez T, Gautier JF, Dutour A, Gonfroy C, Gouet D, Joubert M, Julier I, Larger E, Marchand L, Marre M, Meyer L, Olivier F, Prevost G, Quiniou P, Raffaitin-Cardin C, Roussel R, Saulnier PJ, Seret-Begue D, Thivolet C, Vatier C, Desailloud R, Wargny M, Gourdy P, Cariou B; CORONADO investigators.

COVID-19 Associated with Diabetes and Other Noncommunicable Diseases Led to a Global Health Crisis

Thomaz Ugliara Barone M, Ngongo B, Bega Harnik S, Xavier de Oliveira L, Végh D, Vieira de Luca P, Cordeiro Pedrosa H, Giraudo F, Cardona-Hernandez R, Chaudhury N, Menna-Barreto L.

Costs of COVID-19 pandemic associated with diabetes in Europe: a health care cost model

Bain SC, Czernichow S, Bøgelund M, Madsen ME, Yssing C, McMillan AC, Hvid C, Hettiarachchige N, Haagen Panton U.

Corrigendum to "Prevalence of Diabetes and Hypertension and Their Associated Risks for Poor Outcomes in Covid-19 Patients"

COVID-19 and diabetes: A bidirectional relationship

Lima-Martínez MM, Carrera Boada C, Madera-Silva MD, Marín W, Contreras M.

Clinical Outcomes of COVID-19 Patients with Type 2 Diabetes: A Population-Based Study in Korea

You JH, Lee SA, Chun SY, Song SO, Lee BW, Kim DJ, Boyko EJ.

Novel Molecular Evidence Related to COVID-19 in Patients with Diabetes Mellitus

Liao YH, Zheng JQ, Zheng CM, Lu KC, Chao YC.

Diabetes Mellitus and Hypertension as Major Risk Factors of Mortality From Covid-19 Pneumonia

Petrakis V, Panagopoulos P, Papazoglou D, Papanas N.

Predictors of adverse in-hospital outcome and recovery in patients with diabetes mellitus and COVID-19 pneumonia in Iraq

Nafakhi H, Alareedh M, Al-Buthabhak K, Shaghee F, Nafakhi A, Kasim S.

[Healthcare challenges for people with diabetes during the national state of emergency due to COVID-19 in Lima, Peru: primary healthcare recommendations]

Pesantes MA, Lazo-Porras M, Cárdenas MK, Diez-Canseco F, Tanaka-Zafra JH, Carrillo-Larco RM, Bernabé-Ortiz A, Málaga G, Miranda JJ.

The Impact of Diabetes Mellitus in COVID-19: A Mechanistic Review of Molecular Interactions

Yaribeygi H, Sathyapalan T, Jamialahmadi T, Sahebkar A.

Diabetes and COVID-19-Related Mortality in Women and Men in the UK Biobank: Comparisons With Influenza/Pneumonia and Coronary Heart Disease

de Jong M, Woodward M, Peters SAE.

Disordered eating behaviors in youths with type 1 diabetes during COVID-19 lockdown: an exploratory study

Troncone A, Chianese A, Zanfardino A, Cascella C, Piscopo A, Borriello A, Rollato S, Casaburo F, Testa V, Iafusco D.

Clinical outcomes for COVID-19 patients with diabetes mellitus treated with convalescent plasma transfusion in Wuhan, China

Dai W, Wu J, Li T, Shen J, Pang R, Luo T, Guo Y, Yang Y, Zhao J, Zhang M, Li N, Han Y, Wu Q, Li W, Xia X.

Diabetic Foot Care Before and During the COVID-19 Epidemic: What Really Matters?

Urbančič-Rovan V.

Hyperglycemia associated with lymphopenia and disease severity of COVID-19 in type 2 diabetes mellitus

Cheng Y, Yue L, Wang Z, Zhang J, Xiang G.

Digital Ophthalmology in the UK - Diabetic Retinopathy Screening and Virtual Glaucoma Clinics in the National Health Service

Heimann H, Broadbent D, Cheeseman R.

Thyroid fine-needle aspiration trends before, during, and after the lockdown: what we have learned so far from the COVID-19 pandemic

Palladino R, Migliatico I, Sgariglia R, Nacchio M, Iaccarino A, Malapelle U, Vigliar E, Salvatore D, Troncone G, Bellevicine C.

Clinical Characteristics and Outcomes of Patients With Diabetes Admitted for COVID-19 Treatment in Dubai: Single-Centre Cross-Sectional Study

Bhatti R, Khamis AH, Khatib S, Shiraz S, Matfin G.

Increased DKA at presentation among newly diagnosed type 1 diabetes patients with or without COVID-19; Data from a multi-site surveillance registry

Beliard K, Ebekozien O, Demeterco-Berggren C, Alonso GT, Gallagher MP, Clements M, Rapaport R.

Angiotensin-converting enzyme 2, the complement system, the kallikrein-kinin system, type-2 diabetes, interleukin-6, and their interactions regarding the complex COVID-19 pathophysiological crossroads

Hoevenaar M, Goossens D, Roorda J.

Letter in response to the article: Pros and cons for use of statins in 59 people with coronavirus disease-19 (COVID-19)(Ray, S et al.)

Zhao T, Peng L.

Diabetes and Covid-19 among hospitalized patients in Saudi Arabia: a single-centre retrospective study

Alguwaihes AM, Al-Sofiani ME, Megdad M, Albader SS, Alsari MH, Alelayan A, Alzahrani SH, Sabico S, Al-Daghri NM, Jammah AA.

People living with Type 1 diabetes point of view in COVID-19 times (COVIDT1 Study): disease impact, health system pitfalls and lessons for the future

Tejera C, Moreno-Pérez Ó, Rios J, Reyes-García R.

Coronavirus disease 2019 and type 1 diabetes mellitus

Chang DJ, Moin T.

Angiotensin Converting Enzyme Inhibitors, A Risk Factor of Poor Outcome in Diabetic Patients with COVID-19 Infection

Aghaaliakbari F, Abbasi MA, Ranjbar M, Jamshidi Makiani M, Farrokhpour M, Safarnezhad Tameshkel F, Karbalaie Niya MH, Doltkhah S, Yaghoobzadeh K, Savaj S.

Insulin Use, Diabetes Control, and Outcomes in Patients with COVID-19

Riahi S, Sombra LRS, Lo KB, Chacko SR, Neto AGM, Azmaiparashvili Z, Patarroyo-Aponte G, Rangaswami J, Anastasopoulou C.

Use of MyDesmond digital education programme to support self-management in people with type 2 diabetes during the COVID-19 pandemic

Quinn LM, Davies MJ, Northern A, Brough C, Schreder S, Stribling B, Khunti K, Hadjiconstantinou M.

Development of a fasting blood glucose-based strategy to diagnose women with gestational diabetes mellitus at increased risk of adverse outcomes in a COVID-19 environment

d'Emden M, McLeod D, Ungerer J, Appleton C, Kanowski D.

THE MAIN CAUSES OF THE COMPLICATED COURSE OF COVID-19 IN PATIENTS WITH DIABETES MELLITUS AND TREATMENT (REVIEW)

Halushko O, Loskutov O, Kuchynska I, Synytsyn M, Boliuk M.

What is the role of admission HbA1c in managing COVID-19 patients?

Sathish T, Cao Y.

New thoughts on the diagnosis and treatment of patients with diabetes mellitus in relation to coronavirus disease

Lou XQ, Wang DW, Wang JF, Du B.

COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes

Gregory JM, Slaughter JC, Duffus SH, Smith TJ, LeStourgeon LM, Jaser SS, McCoy AB, Luther JM, Giovannetti ER, Boeder S, Pettus JH, Moore DJ.

Impact of Social Distancing Due to Coronavirus Disease 2019 on the Changes in Glycosylated Hemoglobin Level in People with Type 2 Diabetes Mellitus

Park SD, Kim SW, Moon JS, Lee YY, Cho NH, Lee JH, Jeon JH, Choi YK, Kim MK, Park KG.

COVID-19 and Undiagnosed Pre-diabetes or Diabetes Mellitus Among International Migrant Workers in Singapore

Tee LY, Alhamid SM, Tan JL, Oo TD, Chien J, Galinato P, Tan SY, Humaira S, Fong RKC, Puar TH, Loh WJ, Santosa A, Khoo J, Rosario BH.

COVID-19 Knowledge, Attitudes, and Prevention Practices Among People with Hypertension and Diabetes Mellitus Attending Public Health Facilities in Ambo, Ethiopia

Melesie Taye G, Bose L, Beressa TB, Tefera GM, Mosisa B, Dinsa H, Birhanu A, Umeta G.

Managing diabetes in ageing patients during the COVID-19 pandemic

Armeni E, Paschou SA, Peppa M.

COVID-19's toll on the elderly and those with diabetes mellitus - Is vitamin B12 deficiency an accomplice?

Wee AKH.

Relevance of SARS-CoV-2 related factors ACE2 and TMPRSS2 expressions in gastrointestinal tissue with pathogenesis of digestive symptoms, diabetes-associated mortality, and disease recurrence in COVID-19 patients

Kumar A, Faiq MA, Pareek V, Raza K, Narayan RK, Prasoon P, Kumar P, Kulandhasamy M, Kumari C, Kant K, Singh HN, Qadri R, Pandey SN, Kumar S.

A role of glycation and methylation for SARS-CoV-2 infection in diabetes?

Sartore G, Ragazzi E, Faccin L, Lapolla A.

Ketonuria with or without ketoacidosis as the presenting manifestation of SARS-CoV-2 (COVID-19) among uncontrolled type 2 diabetic patients

Emara MH, Mazid U, Atta MA, Elshahat S, Mahros AM.

Higher ACE2 expression levels in epicardial than subcutaneous stromal cells from patients with cardiovascular disease: Diabetes and obesity as possible enhancer

Couselo-Seijas M, Almengló C, Agra-Bermejo R, Fernandez AL, Alvarez E, González-Juanatey JR, Eiras S.

The Urgent Need for Recommending Physical Activity for the Management of Diabetes During and Beyond COVID-19 Outbreak

Marçal IR, Fernandes B, Viana AA, Ciolac EG.

New Horizons: Does Mineralocorticoid Receptor activation by cortisol cause ATP release and COVID-19 complications?

Edwards C.

Insulin Treatment Is Associated with Increased Mortality in Patients with COVID-19 and Type 2 Diabetes

Yu B, Li C, Sun Y, Wang DW.

Assessing acceptability and patient experience of a behavioral lifestyle intervention using fitbit technology in older adults to manage type 2 diabetes amid COVID-19 pandemic: A focus group study

Jiwani R, Dennis B, Bess C, Monk S, Meyer K, Wang J, Espinoza S.

Glucose or Insulin, Which Is the Culprit in Patients with COVID-19 and Diabetes?

Donath MY.

Proportion of newly diagnosed diabetes in COVID-19 patients: a systematic review and meta-analysis

Sathish T, Kapoor N, Cao Y, Tapp RJ, Zimmet P.

Caring for Hospitalized Patients with Diabetes Mellitus, Hyperglycemia, and COVID-19: Bridging the Remaining Knowledge Gaps

Wallia A, Prince G, Touma E, El Muayed M, Seley JJ.

[Diabetes mellitus in old age]

Zeyfang A, Zeeh J, Bahrmann A, Kugler JN, Heppner HJ.

A Rare Case of COVID-19 Myocarditis With Cardiac Tamponade in a Young Diabetic Adult With Renal Failure

Tiwary T, Baiswar S, Jinnur P.

Remote continuous glucose monitoring during the COVID-19 pandemic in quarantined hospitalized patients in Denmark: A structured summary of a study protocol for a randomized controlled trial

Klarskov CK, Lindegaard B, Pedersen-Bjergaard U, Kristensen PL.

Soluble Receptor for Advanced Glycation End Products and Its Forms in COVID-19 Patients with and without Diabetes Mellitus: A Pilot Study on Their Role as Disease Biomarkers

Dozio E, Sitzia C, Pistelli L, Cardani R, Rigolini R, Ranucci M, Corsi Romanelli MM.

The Potential Role of Osteopontin and Furin in Worsening Disease Outcomes in COVID-19 Patients with Pre-Existing Diabetes

Adu-Agyeiwaah Y, Grant MB, Obukhov AG.

Factors related to improvement of glycemic control among adults with type 1 diabetes during lockdown due to COVID-19

Moreno-Domínguez Ó, González-Pérez de Villar N, Barquiel B, Hillman N, Gaspar-Lafuente R, Arévalo-Gómez M, Herranz L.

Resilience in pregnant women with pre-gestational diabetes during COVID-19 pandemic: the experience of the Papa Giovanni XXIII Hospital in Bergamo, Italy

Dodesini AR, Caffi A, Spada MS, Trevisan R.

A trend towards early increases in ketoacidosis at presentation of pediatric type 1 diabetes during the coronavirus-2019 pandemic

Hawkes CP, Willi SM.

The association of diabetes with COVID-19 disease severity: evidence from adjusted effect estimates

Liang X, Xu J, Xiao W, Shi L, Yang H.

Phenotypic Characteristics and Development of a Hospitalization Prediction Risk Score for Outpatients with Diabetes and COVID-19: The DIABCOVID Study

Lasbleiz A, Cariou B, Darmon P, Soghomonian A, Ancel P, Boullu S, Houssays M, Romain F, Lagier JC, Boucekine M, Resseguier N, Gourdy P, Pichelin M, Wargny M, Dutour A, Gaborit B.

Risk factors associated with the progression of COVID-19 in elderly diabetes patients

Zhang P, Wang M, Wang Y, Wang Y, Li T, Zeng J, Wang L, Li C, Gong Y.

Glycemic Control of Patients with Type 1 Diabetes Using an Insulin Pump Before and During the COVID-19-Associated Quarantine

Barmpagianni A, Lambadiari V, Papazafiropoulou A, Kountouri A, Stergiou A, Melidonis A, Liatis S.

A roadmap to recovery: ABCD recommendations on risk stratification of adult patients with diabetes in the post COVID-19 era

Choudhary P, Wilmot EG, Owen K, Patel DC, Mills L, Rayman G, Winocour P, Ayman G, Patel R, Hambling C, Nagi DK.

Are diabetes and its medications risk factors for the development of COVID-19? Data from a population-based study in Sicily

Silverii GA, Monami M, Cernigliaro A, Vigneri E, Guarnotta V, Scondotto S, Allotta VA, Conti M, Giordano C, Mannucci E.

Higher values of fasting blood glucose and glycated hemoglobin are not associated with mortality in Covid-19 Mexican patients

Gastélum-Cano JM, Islas-Osuna MA, Arízaga-Berber JA.

Diabetes Mellitus is Associated with Severe Infection and Mortality in Patients with COVID-19: A Systematic Review and Meta-analysis

Bud ES, Vlasa A, Bud A.

Obesity, Diabetes, Non-alcoholic Fatty Liver Disease and Metabolic Dysfunction Associated Fatty Liver Disease are Proinflammatory Hypercoagulable States associated with Severe Disease and Thrombosis in Covid-19

Ji D, Zhang M, Qin E, Zhang L, Xu J, Wang Y, Cheng G, Wang F, Lau G.

Short-term impact of COVID-19 lockdown on metabolic control of patients with well-controlled type 2 diabetes: a single-centre observational study

Biancalana E, Parolini F, Mengozzi A, Solini A.

The dark side of the spoon - glucose, ketones and COVID-19: a possible role for ketogenic diet?

Paoli A, Gorini S, Caprio M.

Association of glycosylated hemoglobin and outcomes in patients with COVID-19 and pre-existing type 2 diabetes: A protocol for systematic review and meta-analysis

Zhang N, Yun R, Liu L, Yang L.

Does Inpatient Hyperglycemia predict a worse outcome in COVID-19 Intensive Care Unit Patients?

Saand AR, Flores M, Kewan T, Alqaisi S, Alwakeel M, Griffiths L, Wang X, Han X, Burton R, Al Jaghbeer MJ, Fadel FA.

Pre-diabetes and COVID-19, could we be missing the silent killer?

Sosibo AM, Khathi A.

Diabetes and COVID-19: a major challenge in pandemic period?

Chakraborty C, Sharma AR, Bhattacharya M, Sharma G, Agoramoorthy G, Lee SS.

Coagulopathy is a major extrapulmonary risk factor for mortality in hospitalized patients with COVID-19 with type 2 diabetes

Chen X, Chen Y, Wu C, Wei M, Xu J, Chao YC, Song J, Hou D, Zhang Y, Du C, Li X, Song Y.

COVID-19: No one must be left behind

Tieri L.

[Covid-19 and diabetes]

Paquot N, Radermecker RP.

M♡THer, a mHealth System to Support Women with Gestational Diabetes Mellitus - Feasibility and Acceptability Study

Varnfield M, Redd C, Stoney R, Higgins L, Scolari N, Warwick R, Iedema J, Rundle J, Dutton W.

The potential effects of clinical antidiabetic agents on SARS-CoV-2

Qu H, Zheng Y, Wang Y, Li H, Liu X, Xiong X, Zhang L, Gu J, Yang G, Zhu Z, Zheng H, Ouyang Q.

Recent trends for the management of diabetes for older adults in the context of universal coverage and COVID-19: evidence from Mexico

Arredondo A.

COVID 19 and diabetes: An endocrinologist's perspective

Behera KK, Hota D, Mahapatra A.

Characteristics and outcomes of diabetic patients infected by the SARS-CoV-2

Elamari S, Motaib I, Zbiri S, Elaidaoui K, Chadli A, Elkettani C.

Incremental Risk of Developing Severe COVID-19 Among Mexican Patients With Diabetes Attributed to Social and Health Care Access Disadvantages

Sosa-Rubí SG, Seiglie JA, Chivardi C, Manne-Goehler J, Meigs JB, Wexler DJ, Wirtz VJ, Gómez-Dantés O, Serván-Mori E.

Innovations in Diabetes Care for a Better "New Normal" Beyond COVID-19

Agarwal S, Griffith ML, Murphy EJ, Greenlee C, Boord J, Gabbay RA.

Children and youth with diabetes are not at increased risk for hospitalization due to COVID-19

Cardona-Hernandez R, Cherubini V, Iafusco D, Schiaffini R, Luo X, Maahs DM.

Prevalence of readily detected amyloid blood clots in 'unclotted' Type 2 Diabetes Mellitus and COVID-19 plasma: a preliminary report

Pretorius E, Venter C, Laubscher GJ, Lourens PJ, Steenkamp J, Kell DB.

An Immediate and Long-Term Complication of COVID-19 May Be Type 2 Diabetes Mellitus: The Central Role of β-Cell Dysfunction, Apoptosis and Exploration of Possible Mechanisms

Hayden MR.

Furin Protease: From SARS CoV-2 to Anthrax, Diabetes, and Hypertension

Fitzgerald K.

Use of DPP-4 inhibitors in patients with COVID-19

Kow CS, Hasan SS.

Reply to letter to the editor regarding "Use of DPP-4 inhibitors in patients with COVID-19"

Solerte SB, D'Addio F, Fiorina P.

Covid-19 fatality prediction in people with diabetes and prediabetes using a simple score at hospital admission

Sourij H, Aziz F, Bräuer A, Ciardi C, Clodi M, Fasching P, Karolyi M, Kautzky-Willer A, Klammer C, Malle O, Oulhaj A, Pawelka E, Peric S, Ress C, Sourij C, Stechemesser L, Stingl H, Stulnig TM, Tripolt N, Wagner M, Wolf P, Zitterl A, Kaser S; COVID-19 in Diabetes in Austria - study group.

Host genetic liability for severe COVID-19 overlaps with alcohol drinking behavior and diabetic outcomes and in over 1 million participants

Wendt FR, De Lillo A, Pathak GA, De Angelis F, Polimanti R.

Images of the month: An incidental finding of spontaneous pneumomediastinum (Hamman's syndrome) secondary to diabetic ketoacidosis during the coronavirus pandemic

Marchon KA, Nunn MO, Chakera AJ.

Maintaining Blood Glucose Levels in Range (70-150 mg/dL) is Difficult in COVID-19 Compared to Non-COVID-19 ICU Patients-A Retrospective Analysis

Kapoor R, Timsina LR, Gupta N, Kaur H, Vidger AJ, Pollander AM, Jacobi J, Khare S, Rahman O.

Blood Glucose Control Strategy for Type 2 Diabetes Patients With COVID-19

Futatsugi H, Iwabu M, Okada-Iwabu M, Okamoto K, Amano Y, Morizaki Y, Kadowaki T, Yamauchi T.

COVID-19 Precipitating Euglycaemic Diabetic Ketoacidosis with SGLT2 Inhibitor Use

Fang J, Genco M, Caskey RN.

Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study

Pérez-Belmonte LM, Torres-Peña JD, López-Carmona MD, Ayala-Gutiérrez MM, Fuentes-Jiménez F, Huerta LJ, Muñoz JA, Rubio-Rivas M, Madrazo M, Garcia MG, Montes BV, Sola JF, Ena J, Ferrer RG, Pérez CM, Ripper CJ, Lecumberri JJN, Acedo IEA, Canteli SP, Cosío SF, Martínez FA, Rodríguez BC, Pérez-Martínez P, Ramos-Rincón JM, Gómez-Huelgas R; SEMI-COVID-19 Network.

Prevalence of Diabetes, Management and Outcomes among Covid-19 Adult Patients Admitted in a Specialized Tertiary Hospital in Riyadh, Saudi Arabia

Sheshah E, Sabico S, Albakr RM, Sultan AA, Alghamdi KS, Al Madani K, Alotair HA, Al-Daghri NM.

Could a family history of type 2 diabetes be a risk factor to the endothelial damage in the patient with COVID-19?

Alvarado-Vasquez N.

COVID-19 and diabetes mellitus: from pathophysiology to clinical management

Lim S, Bae JH, Kwon HS, Nauck MA.

Impact of lockdown for COVID-19 pandemic in Indian children and youth with type 1 diabetes from different socio-economic classes

Shah N, Karguppikar M, Bhor S, Ladkat D, Khadilkar V, Khadilkar A.

An inaugural diabetic ketoacidosis with acute pancreatitis during COVID-19

Tollard C, Champenois V, Delemer B, Carsin-Vu A, Barraud S.

Thyroid function before, during and after COVID-19

Khoo B, Tan T, Clarke SA, Mills EG, Patel B, Modi M, Phylactou M, Eng PC, Thurston L, Alexander EC, Meeran K, Comninos AN, Abbara A, Dhillo WS.

Women with mild fasting hyperglycemia in early pregnancy have more neonatal intensive care admissions

Benhalima K, Van Crombrugge P, Moyson C, Verhaeghe J, Vandeginste S, Verlaenen H, Vercammen C, Maes T, Dufraimont E, De Block C, Jacquemyn Y, Mekahli F, De Clippel K, Van Den Bruel A, Loccufier A, Laenen A, Minschart C, Devlieger R, Mathieu C.

New onset diabetes with diabetic ketoacidosis in a child with multisystem inflammatory syndrome due to COVID-19

Naguib MN, Raymond JK, Vidmar AP.

A review of COVID-19 vaccines and major considerations for diabetic patients

Soltani S, Zandi M, Aghbash PS, Rezaei M, Mohammadzadeh N, Afsharifar A, Poortahmasebi V.

COVID-19 in the United States: Where are we now? Where have we been?

Bloomgarden Z.

Sex differences in COVID-19: the role of androgens in disease severity and progression

Mohamed MS, Moulin TC, Schiöth HB.

COVID-19 in People with Diabetes: Perspectives from Saudi Arabia

Robert AA, Al Dawish MA.

Impact of COVID-19 Lockdown on Glycemic Control in Adults with Type 1 Diabetes Mellitus

Pla B, Arranz A, Knott C, Sampedro M, Jiménez S, Hernando I, Marazuela M.

Clinical features of critically ill patients infected with SARS-CoV-2 outside Wuhan with and without diabetes

Peng X, Chen Y, Deng L, Liu Q, Li Q, Xiong J, Shi Y, Tang S.

Telemonitoring type 1 diabetes patients during the COVID-19 pandemic in Brazil: was it useful?

de Mattos Matheus AS, Cabizuca CA, Tannus LRM, Passos AC, Schmidt AC, de Gouveia AT, de Albuquerque Pessoa BM, Matheus FC, Yang GY, da Silva Divino JA, Mathiles JA, Teixeira JL, de Souza Barroso L, da Fonseca de Brito MB, Suassuna PM, Cobas RA.

Hypocalcemia is a distinctive biochemical feature of hospitalized COVID-19 patients

di Filippo L, Formenti AM, Doga M, Frara S, Rovere-Querini P, Bosi E, Carlucci M, Giustina A.

COVID-19 Hospitalization in Adults with Type 1 Diabetes: Results from the T1D Exchange Multi-Center Surveillance Study

O'Malley G, Ebekozien O, Desimone M, Pinnaro CT, Roberts A, Polsky S, Noor N, Aleppo G, Basina M, Tansey M, Steenkamp D, Vendrame F, Lorincz I, Mathias P, Agarwal S, Golden L, Hirsh IB, Levy CJ.

Letter to the Editor regarding 'COVID-19 and diabetes: What does the clinician need to know?'

Abbasi-Oshaghi E, Mirzaei F, Khodadadi I.

Charlson comorbidity index and a composite of poor outcomes in COVID-19 patients: A systematic review and meta-analysis

Tuty Kuswardhani RA, Henrina J, Pranata R, Anthonius Lim M, Lawrensia S, Suastika K.

Differential white blood cell count in the COVID-19: A cross-sectional study of 148 patients

Anurag A, Jha PK, Kumar A.

Is there an association between metformin use and clinical outcomes in diabetes patients with COVID-19?

Do JY, Kim SW, Park JW, Cho KH, Kang SH.

Radiological Thoracic Vertebral Fractures are Highly Prevalent in COVID-19 and Predict Disease Outcomes

di Filippo L, Formenti AM, Doga M, Pedone E, Rovere-Querini P, Giustina A.

Vitamin D Status in Hospitalized Patients with SARS-CoV-2 Infection

Hernández JL, Nan D, Fernandez-Ayala M, García-Unzueta M, Hernández-Hernández MA, López-Hoyos M, Muñoz-Cacho P, Olmos JM, Gutiérrez-Cuadra M, Ruiz-Cubillán JJ, Crespo J, Martínez-Taboada VM.

Do biomarkers of COVID-19 severity simply reflect a stress response in type 2 diabetes: Biomarker response to hypoglycemia

Moin ASM, Al-Qaissi A, Sathyapalan T, Atkin SL, Butler AE.

Onset of Ketosis-Prone Diabetes in the Setting of COVID-19 Infection

Siddiqui RS, Zirkiyeva M, Saliaj M.

TEMPORARY REMOVAL: Diabetic retinopathy is independently associated with increased risk of intubation: a single centre cohort study of patients with diabetes hospitalised with COVID-19

Corcillo A, Cohen S, Li A, Crane J, Kariyawasam D, Karalliedde J.

Severity in pediatric type 1 diabetes mellitus debut during the COVID-19 pandemic

Güemes M, Storch-de-Gracia P, Enriquez SV, Martín-Rivada Á, Brabin AG, Argente J.

Social Determinants of Poor Management of Type 2 Diabetes Among the Insured

Patel MR.

The Danger of Sedentary Lifestyle in Diabetic and Obese People During the COVID-19 Pandemic

Lim MA, Pranata R.

Treating diabetic all-comers with contemporary drug-eluting stents: Prespecified comparisons from the BIO-RESORT and the BIONYX randomized trials

Ploumen EH, Buiten RA, Kok MM, Doggen CJM, Roguin A, Jessurun GAJ, Schotborgh CE, Danse PW, Benit E, Aminian A, van Houwelingen KG, Stoel MG, Scholte M, Hartmann M, Linssen GCM, Zocca P, von Birgelen C.

Thyroid Dysfunction in Relation to Immune Profile, Disease Status and Outcome in 191 Patients with COVID-19

Lui DTW, Lee CH, Chow WS, Lee ACH, Tam AR, Fong CHY, Law CY, Leung EKH, To KKW, Tan KCB, Woo YC, Lam CW, Hung IFN, Lam KSL.

Thyroid hormone concentrations in severely or critically ill patients with COVID-19

Gao W, Guo W, Guo Y, Shi M, Dong G, Wang G, Ge Q, Zhu J, Zhou X.

Antidiabetes Agents against Sars-Cov-2 Infection

Vitiello A, Ferrara F.

Implications of COVID-19 Pandemic on Evolution of Diabetes in Malaria-Endemic African Region

Acquah S.

COVID-19-associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes on SGLT2 inhibitor: a case report

Batista DV, Vieira CAFA, Costa TA, Lima EG.

Prevalence and impact of diabetes in patients with COVID-19 in China

Du M, Lin YX, Yan WX, Tao LY, Liu M, Liu J.

Covid-19 and Diabetes: A Complex Bidirectional Relationship

Muniangi-Muhitu H, Akalestou E, Salem V, Misra S, Oliver NS, Rutter GA.

Diabetic ketoacidosis precipitated by Coronavirus disease 2019 infection: Case series

Alsadhan I, Alruwashid S, Alhamad M, Alajmi S, Alshehri S, Alfadhli E, Ekhzaimy A.

Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes

Sathish T, Tapp RJ, Cooper ME, Zimmet P.

Response to: Is newly diagnosed diabetes a stronger risk factor than pre-existing diabetes for COVID-19 severity?

Lippi G, Sanchis-Gomar F, Henry BM.

Prenatal exposure to gestational diabetes is associated with anxiety and physical inactivity in children during COVID-19

Alves JM, Yunker AG, DeFendis A, Xiang AH, Page KA.

The Toll of Lockdown Against COVID-19 on Diabetes Outpatient Care. Analysis from an outbreak area in North-East Italy

Bonora BM, Morieri ML, Avogaro A, Fadini GP.

The influence of hypoglycemia and hyperglycemia on the adverse outcome of COVID-19 combined with diabetes mellitus: A protocol for systematic review and meta-analysis

Yang Y, Chen XFD, Chen Y, Xie H, Xie C, Ying L.

Analysis of clinical features and pulmonary CT features of coronavirus disease 2019 (COVID-19) patients with diabetes mellitus

Yan Y, Yang F, Zhu X, Wang M, Sun Z, Zhao T, Yang X, Zou Y.

Management of glucose profile throughout strict COVID-19 lockdown by patients with type 1 diabetes prone to hypoglycaemia using sensor-augmented pump

Viñals C, Mesa A, Roca D, Vidal M, Pueyo I, Conget I, Giménez M.

Diabetes is associated with increased risk for in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis comprising 18,506 patients

Palaiodimos L, Chamorro-Pareja N, Karamanis D, Li W, Zavras PD, Chang KM, Mathias P, Kokkinidis DG.

The Importance of Telemedicine during COVID-19 Pandemic: A Focus on Diabetic Retinopathy

Galiero R, Pafundi PC, Nevola R, Rinaldi L, Acierno C, Caturano A, Salvatore T, Adinolfi LE, Costagliola C, Sasso FC.

Prevention and Management of Type 2 Diabetes and Metabolic Syndrome in the Time of COVID-19: Should We Add a Cup of Coffee?

Semiz S, Serdarevic F.

The Impact of COVID-19 on Blood Glucose: A Systematic Review and Meta-Analysis

Chen J, Wu C, Wang X, Yu J, Sun Z.

The adverse effects of novel coronavirus on diabetic foot patients: A protocol for systematic review and meta analysis

Chen D, Zhou H, Yang Y, Zhang Y, Xie C.

Statins and SARS-CoV-2 disease: Current concepts and possible benefits

Minz MM, Bansal M, Kasliwal RR.

Challenges in Women with Diabetes During the COVID-19 Pandemic

Priya G, Bajaj S, Grewal E, Maisnam I, Chandrasekharan S, Selvan C.

Managing Diabetes During the COVID-19 Pandemic

Doupis J, Avramidis K.

Barriers to Self-Management of Type 2 Diabetes During COVID-19 Medical Isolation: A Qualitative Study

Shi C, Zhu H, Liu J, Zhou J, Tang W.

Comparison of the effects of lockdown due to COVID-19 on glucose patterns among children, adolescents, and adults with type 1 diabetes: CGM study

Di Dalmazi G, Maltoni G, Bongiorno C, Tucci L, Di Natale V, Moscatiello S, Laffi G, Pession A, Zucchini S, Pagotto U.

Euglycemic Diabetic Ketoacidosis Associated with Empagliflozin Use in the Course of the SARS-Cov-2 Pandemic

Ozer O, Yorulmaz G.

Independent Impact of Diabetes on the Severity of Coronavirus Disease 2019 in 5,307 Patients in South Korea: A Nationwide Cohort Study

Moon SJ, Rhee EJ, Jung JH, Han KD, Kim SR, Lee WY, Yoon KH.

Short term follow-up of patients presenting with acute onset diabetes and diabetic ketoacidosis during an episode of COVID-19

Kuchay MS, Reddy PK, Gagneja S, Mathew A, Mishra SK.

Clinical characteristics and short term outcomes after recovery from COVID-19 in patients with and without diabetes in Bangladesh

Akter F, Mannan A, Mehedi HMH, Rob MA, Ahmed S, Salauddin A, Hossain MS, Hasan MM.

Multidimensional Analysis of Risk Factors for the Severity and Mortality of Patients with COVID-19 and Diabetes

Huang J, Zhu L, Bai X, Jia X, Lu Y, Deng A, Li J, Jin S.

Inpatient Diabetes Care during the COVID-19 Pandemic: A Diabetes UK rapid review of health care professionals' experiences using semi-structured interviews

Burr O, Berry A, Joule N, Rayman G.

Coronavirus disease 2019 (COVID-19): Insights into the recent trends and the role of the primary care in diabetic patients

Marghalani AM, Althumali IM, Yousef LM, Alharthi MA, Alahmari ZS, Kabel AM.

Management of diabetes during fasting and COVID-19 - Challenges and solutions

Ahmed WN, Arun CS, Koshy TG, Nair A, Sankar P, Rasheed SA, Ann R.

Is newly diagnosed diabetes a stronger risk factor than pre-existing diabetes for COVID-19 severity?

Sathish T, de Mello GT, Cao Y.

Adrenal insufficiency at the time of COVID-19: a retrospective study in patients referring to a tertiary centre

Carosi G, Morelli V, Del Sindaco G, Serban AL, Cremaschi A, Frigerio S, Rodari G, Profka E, Indirli R, Mungari R, Resi V, Orsi E, Ferrante E, Dolci A, Giavoli C, Arosio M, Mantovani PG.

A post COVID-19 "Marshall Plan" for type 2 diabetes

Petrie JR, Boyle JG, Ali K, Smith C, Morrison D, Kar P.

Improved glycemic control amongst people with long-standing diabetes during COVID-19 lockdown: a prospective, observational, nested cohort study

Rastogi A, Hiteshi P, Bhansali A.

COVID-19-Induced Diabetic Ketoacidosis and Acute Respiratory Distress Syndrome in an Obese 24-Year-Old Type I Diabetic

Singh S, Foster A, Khan Z, Siddiqui A, Atere M, Nfonoyim JM.

Biological response modifier glucan through balancing of blood glucose may have a prophylactic potential in COVID-19 patients

Ikewaki N, Iwasaki M, Abraham SJK.

The burden of type 2 diabetes pre-and during the COVID-19 pandemic - a review

Sciberras J, Camilleri LM, Cuschieri S.

Macrophages in diabetes mellitus (DM) and COVID-19: do they trigger DM?

Kloc M, Ghobrial RM, Lewicki S, Kubiak JZ.

COVID-19 and diabetes mellitus: Unraveling the hypotheses that worsen the prognosis (Review)

Albulescu R, Dima SO, Florea IR, Lixandru D, Serban AM, Aspritoiu VM, Tanase C, Popescu I, Ferber S.

SARS-CoV 2 (Covid-19) Heterogeneous Mortality Rates across Countries May Be Partly Explained by Life Expectancy, Calorie Intake, and Prevalence of Diabetes

Nkhata SG, Ngoma TN, Chilenga PM.

High prevalence of Afro-Caribbean ethnicity and hypoglycaemia in patients with diabetes and end stage renal disease hospitalised with COVID-19

Corcillo A, Cohen S, Game D, Karalliedde J.

Management of gestational diabetes in women with a concurrent Sars-Cov-2 infection, experience of a single center in Northern Italy

D'Ambrosi F, Rossi G, Soldavini CM, Maggi V, Cetera GE, Carbone IF, Di Martino D, Di Maso M, Ferrazzi E.

Mechanistic basis and therapeutic relevance of hypocalcemia during severe COVID-19 infection

Singh VP, Khatua B, El-Kurdi B, Rood C.

Impact of COVID-19 on lifestyle-related behaviours- a cross-sectional audit of responses from nine hundred and ninety-five participants from India

Chopra S, Ranjan P, Singh V, Kumar S, Arora M, Hasan MS, Kasiraj R, Suryansh, Kaur D, Vikram NK, Malhotra A, Kumari A, Klanidhi KB, Baitha U.

Young people with type 1 diabetes on insulin pump therapy could fast safely during COVID 19 pandemic Ramadan - a telemonitoring experience in Bangladesh

Zabeen B, Ahmed B, Nahar J.

Type 2 Diabetes and COVID-19-Related Mortality in the Critical Care Setting: A National Cohort Study in England, March-July 2020

Dennis JM, Mateen BA, Sonabend R, Thomas NJ, Patel KA, Hattersley AT, Denaxas S, McGovern AP, Vollmer SJ.

Normal weight obesity and COVID-19 severity: A poorly recognized link

Sathish T, Kapoor N.

Impact of obesity, fasting plasma glucose level, blood pressure, and renal function on the severity of COVID-19: a matter of sexual dimorphism?

Huh K, Lee R, Ji W, Kang M, Cheol Hwang I, Ho Lee D, Jung J.

Potential Safety Issues with Use of Sodium-Glucose Cotransporter 2 Inhibitors, Particularly in People with Type 2 Diabetes and Chronic Kidney Disease

Milder TY, Stocker SL, Day RO, Greenfield JR.

Hypocalcemia: the quest for the cause of a major biochemical feature of COVID-19

di Filippo L, Formenti AM, Giustina A.

Managing high-acuity outpatient services during the COVID-19 pandemic: lessons from the acute diabetes foot service

Deogon GS, Robbins T, Randeva MS, Kyrou I, Sankar S, Randeva HS, Murthy N.

The role of androgens in COVID-19

Moradi F, Enjezab B, Ghadiri-Anari A.

Routine use of statins and increased mortality related to COVID-19 in inpatients with type 2 diabetes: Results from the CORONADO study

Cariou B, Goronflot T, Rimbert A, Boullu S, Le May C, Moulin P, Pichelin M, Potier L, Smati S, Sultan A, Tramunt B, Wargny M, Gourdy P, Hadjadj S; CORONADO investigators.

COVID-19 in People with Diabetes: Epidemiological Perspectives and Public Health Actions in the Middle East and North Africa (MENA) Region

Al Dawish MA, Robert AA.

Use of Continuous Glucose Monitoring to Assess TPN-induced Hyperglycemia in an Adult Patient with Severe COVID-19

Chow KW, Kelly DJ, Gupta R, Miller JD.

Proposed Use of Continuous Glucose Monitoring for Care of Critically Ill COVID-19 Patients

Jankovic I, Basina M.

The Value of Telemedicine for the Follow-up of Patients with New Onset Type 1 Diabetes Mellitus During COVID-19 Pandemic in Turkey: A Report of Eight Cases

Evin F, Er E, Ata A, Jalilova A, Demir G, Atik Altınok Y, Özen S, Darcan Ş, Gökşen D.

Incidental COVID-19 Pneumonia on Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography: The "New-normal"

Sharma P.

Response to Comment on McIntyre and Moses The Diagnosis and Management of Gestational Diabetes Mellitus in the Context of the COVID-19 Pandemic. Diabetes Care 2020;43:1433-1434

McIntyre HD, Moses RG.

Comment on McIntyre and Moses The Diagnosis and Management of Gestational Diabetes Mellitus in the Context of the COVID-19 Pandemic. Diabetes Care 2020;43:1433-1434

Issa BG, Becker L, Cheer K, Kelly AM.

A nutritional web-based approach in obesity and diabetes before and during COVID-19 lockdown

Fraticelli F, Nicola MD, Vitacolonna E.

Application of tele-podiatry in diabetic foot management: A series of illustrative cases

Kavitha KV, Deshpande SR, Pandit AP, Unnikrishnan AG.

Comments on "ARIMA modelling & forecasting of COVID-19 in top five affected countries"(by Alok Kumar Sahai, Namita Rath, Vishal Sood, Manvendra Pratap Singh)

Kufel T, Kufel P.

Diabetes, D-dimer and COVID-19: The possible role of glucose control

Ceriello A.

The impact of metabolic syndrome on morbidity and mortality among intensive care unit admitted COVID-19 patients

Alamdari NM, Rahimi FS, Afaghi S, Zarghi A, Qaderi S, Tarki FE, Ghafouri SR, Besharat S.

COVID-19: Impact of obesity and diabetes on disease severity

Al-Sabah S, Al-Haddad M, Al-Youha S, Jamal M, Almazeedi S.

Prise en charge du diabète de type 2 en soins primaires durant la pandémie de la COVID-19

Kiran T, Moonen G, Bhattacharyya OK, Agarwal P, Bajaj HS, Kim J, Ivers N.

Managing type 2 diabetes in primary care during COVID-19

Kiran T, Moonen G, Bhattacharyya OK, Agarwal P, Bajaj HS, Kim J, Ivers N.

Decentralized COVID-19 measures in Brazil were ineffective to protect people with diabetes

Ugliara Barone MT, Harnik SB, Chaluppe M, Vieira de Luca P, Ngongo B, Pedrosa HC, Pirolo V, Franco DR, Malta DC, Giampaoli V.

Effects of work status changes and perceived stress on glycaemic control in individuals with type 1 diabetes during COVID-19 lockdown in Italy

Barchetta I, Agata Cimini F, Bertoccini L, Ceccarelli V, Spaccarotella M, Giorgio Baroni M, Gisella Cavallo M.

Diabetes begünstigt Nierenversagen bei COVID-19-Patienten : Corona-Pandemie -- Autor: E. Fritschka

Fritschka E.

Time in range: a best practice guide for UK diabetes healthcare professionals in the context of the COVID-19 global pandemic

Wilmot EG, Lumb A, Hammond P, Murphy HR, Scott E, Gibb FW, Platts J, Choudhary P.

Effect of COVID-19 pandemic on treatment of Type 1 diabetes in children

Ludvigsson J.

Admission fasting plasma glucose is an independent risk factor for 28-day mortality in patients with COVID-19

Yang P, Wang N, Wang J, Luo A, Gao F, Tu Y.

Factors associated with the poor outcomes in diabetic patients with COVID-19

Rastad H, Ejtahed HS, Mahdavi-Ghorabi A, Arzaghi M, Safari A, Shahrestanaki E, Rezaei M, Niksima MM, Zakani A, Dehghan Manshadi SH, Ochi F, Saedi S, Khodaparast Z, Shafiabadi Hassani N, Azimzadeh M, Qorbani M.

Evaluation of telephone and virtual visits for routine pediatric diabetes care during the COVID-19 pandemic

Fung A, Irvine M, Ayub A, Ziabakhsh S, Amed S, Hursh BE.

Risk Factors for Poor Outcomes of Diabetes Patients With COVID-19: A Single-Center, Retrospective Study in Early Outbreak in China

Zhang N, Wang C, Zhu F, Mao H, Bai P, Chen LL, Zeng T, Peng MM, Qiu KL, Wang Y, Yu M, Xu S, Zhao J, Li N, Zhou M.

Practical Considerations for the Management of Cushing's Disease and COVID-19: A Case Report

Beretta F, Dassie F, Parolin M, Boscari F, Barbot M, Busetto L, Mioni R, De Carlo E, Scaroni C, Fallo F, Vettor R, Maffei P.

SARS-CoV-2 infection in patients with diabetes mellitus and hypertension: a systematic review

Deravi N, Fathi M, Vakili K, Yaghoobpoor S, Pirzadeh M, Mokhtari M, Fazel T, Ahsan E, Ghaffari S.

Effects of COVID-19 pandemic lockdown on gestational diabetes mellitus: A retrospective study

Ghesquière L, Garabedian C, Drumez E, Lemaître M, Cazaubiel M, Bengler C, Vambergue A.

Factors contributing to glycemic control in diabetes mellitus patients complying with home quarantine during the coronavirus disease 2019 (COVID-19) epidemic

Tao J, Gao L, Liu Q, Dong K, Huang J, Peng X, Yang Y, Wang H, Yu X.

Seasonal flu and COVID-19 recommendations for children, adolescents and young adults with diabetes

Scaramuzza AE, Rabbone I, Maffeis C, Schiaffini R; Diabetes Study Group of the Italian Society for Pediatric Endocrinology, Diabetes.

Impact of COVID-19 lockdown on flash and real-time glucose sensor users with type 1 diabetes in England

Prabhu Navis J, Leelarathna L, Mubita W, Urwin A, Rutter MK, Schofield J, Thabit H.

Identification and Resolution of Asymptomatic COVID-19 Pneumonitis and Colitis: Serial Assessment of Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography for Evaluation of Lung Cancer

Kidane B, Levin DP.

Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report

Jornayvaz FR, Assouline B, Pugin J, Gariani K.

Deadly Companions: COVID-19 and Diabetes in Mexico

Singer M.

Continuous Glucose Monitoring in Critically Ill Patients With COVID-19: Results of an Emergent Pilot Study

Sadhu AR, Serrano IA, Xu J, Nisar T, Lucier J, Pandya AR, Patham B.

Admission hyperglycemiaas a predictor of mortality in patients hospitalized with COVID-19 regardless of diabetes status: Data from the Spanish SEMI-COVID-19 Registry

Carrasco-Sánchez FJ, López-Carmona MD, Martínez-Marcos FJ, Pérez-Belmonte LM, Hidalgo-Jiménez A, Buonaiuto V, Suárez Fernández C, Freire Castro SJ, Luordo D, Pesqueira Fontan PM, Blázquez Encinar JC, Magallanes Gamboa JO, de la Peña Fernández A, Torres Peña JD, Fernández Solà J, Napal Lecumberri JJ, Amorós Martínez F, Guisado Espartero ME, Jorge Ripper C, Gómez Méndez R, Vicente López N, Román Bernal B, Rojano Rivero MG, Ramos Rincón JM, Gómez Huelgas R; SEMI-COVID-19 Networ

Clinical Features of COVID-19 Patients with Diabetes and Secondary Hyperglycemia

Zhou W, Ye S, Wang W, Li S, Hu Q.

Distinguishable Immunologic Characteristics of COVID-19 Patients with Comorbid Type 2 Diabetes Compared with Nondiabetic Individuals

Zhao R, Sun Y, Zhang Y, Wang W, Wang S, Wang C, Liu J, Gao L, Hu Z, Fei J, Hou X, Zheng H, Chen L.

Effect of COVID-19-associated lockdown on the metabolic control of patients with type 2 diabetes

Psoma O, Papachristoforou E, Kountouri A, Balampanis K, Stergiou A, Lambadiari V, Liatis S, Tsimihodimos V.

The early impact of the COVID-19 pandemic on adults with type 1 or type 2 diabetes: A national cohort study

Fisher L, Polonsky W, Asuni A, Jolly Y, Hessler D.

Effect of COVID19 pandemic and national lockdown on persons with diabetes from rural areas availing care in a tertiary care center, southern India

Olickal JJ, Chinnakali P, Suryanarayana BS, Ulaganeethi R, Kumar SS, Saya GK.

The effect of COVID-19 lockdown on glycemic control in patients with type 2 diabetes mellitus in Turkey

Önmez A, Gamsızkan Z, Özdemir Ş, Kesikbaş E, Gökosmanoğlu F, Torun S, Cinemre H.

Estimated HbA(1c) and glucose management indicator (GMI): are they the same?

Leelarathna L, Thabit H, Hovorka R, Evans M.

Pharmacotherapeutic considerations for the management of diabetes mellitus among hospitalized COVID-19 patients

Hasan SS, Kow CS, Bain A, Kavanagh S, Merchant HA, Hadi MA.

Sodium-Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions

Patoulias D, Papadopoulos C, Katsimardou A, Toumpourleka M, Doumas M.

A Response To: Sodium-Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions

Bossi AC, Forloni F, Colombelli PL.

Relationship between obesity and severe COVID-19 outcomes in patients with type 2 diabetes: results from the CORONADO study

Smati S, Tramunt B, Wargny M, Caussy C, Gaborit B, Vatier C, Vergès B, Ancelle D, Amadou C, Bachir LA, Bourron O, Coffin-Boutreux C, Barraud S, Dorange A, Fremy B, Gautier JF, Germain N, Larger E, Laugier-Robiolle S, Meyer L, Monier A, Moura I, Potier L, Sabbah N, Seret-Bégué D, Winiszewski P, Pichelin M, Saulnier PJ, Hadjadj S, Cariou B, Gourdy P; CORONADO investigators.

Fasting Blood Glucose and COVID-19 Severity: Nonlinearity Matters

Alahmad B, Al-Shammari AA, Bennakhi A, Al-Mulla F, Ali H.

Surgical treatment of diabetic foot ulcers during the COVID-19 pandemic in China

Tao F, Tang X, Tao H, Luo Y, Cao H, Xiang W, Zhao Y, Jin L.

COVID-19 and diabetes: No time to drag our feet during an untimely pandemic

Kyrou I, Robbins T, Randeva HS.

COVID-19 And Type 2 Diabetes Mellitus: Hydroxychloroquine May Be The Holy Grail

Pal R, Bhasin MK, Bhadada SK.

Clouds and Silver Linings.COVID-19 Pandemic Is an Opportune Moment to Democratize Diabetes Care Through Telehealth

Kerr D, Warshaw H.

Important Role of Relaxation Techniques on Immune Functions, Glycemic Control, and Stress in Diabetic patients with COVID-19: A Review

Mahmoud Mohamed AA, Alawna M.

Obesity, Diabetes and COVID-19: An Infectious Disease Spreading From the East Collides With the Consequences of an Unhealthy Western Lifestyle

Holly JMP, Biernacka K, Maskell N, Perks CM.

Mediterranean Diet and COVID-19: Hypothesizing Potential Benefits in People With Diabetes

Maiorino MI, Bellastella G, Longo M, Caruso P, Esposito K.

Elevated fasting blood glucose within the first week of hospitalization was associated with progression to severe illness of COVID-19 in patients with pre-existing diabetes: a multicenter observational study

Ling P, Luo S, Zheng X, Cai G, Weng J.

Sperm cryopreservation during the SARS-CoV-2 pandemic

Paoli D, Pallotti F, Nigro G, Aureli A, Perlorca A, Mazzuti L, Di Carlo D, Turriziani O, Lenzi A, Lombardo F.

Pattern of liver function and clinical profile in COVID-19: A cross-sectional study of 91 patients

Kumar A, Kumar P, Dungdung A, Kumar Gupta A, Anurag A, Kumar A.

SARS-CoV-2 receptor networks in diabetic and COVID-19 associated kidney disease

Menon R, Otto EA, Sealfon R, Nair V, Wong AK, Theesfeld CL, Chen X, Wang Y, Boppana AS, Luo J, Yang Y, Kasson PM, Schaub JA, Berthier CC, Eddy S, Lienczewski CC, Godfrey B, Dagenais SL, Sohaney R, Hartman J, Fermin D, Subramanian L, Looker HC, Harder JL, Mariani LH, Hodgin JB, Sexton JZ, Wobus CE, Naik AS, Nelson RG, Troyanskaya OG, Kretzler M.

Type 2 diabetic Asian Indians and COVID-19: Lessons learnt so far from the ongoing pandemic

Shivane VK, Lila AR, Bandgar TR.

Toddler With New Onset Diabetes and Atypical Hemolytic Uremic Syndrome in the Setting of COVID-19

Alizadeh F, O'Halloran A, Alghamdi A, Chen C, Trissal M, Traum A, DeCourcey D.

Relation of D-dimer levels of COVID-19 patients with diabetes mellitus

Mishra Y, Pathak BK, Mohakuda SS, Tilak TVSVGK, Sen S, P H, Singh R, Singh AR.

Glycemic control prior to admission is an important determinant of prognosis in patients with Coronavirus Disease 2019

Liu L, Wei W, Yang K, Li S, Yu X, Dong C, Zhang B.

Ivermectin in COVID-19: What do we know?

Pandey S, Pathak SK, Pandey A, Salunke AA, Chawla J, Sharma A, Sharma S, Thivari P, Ratna HVK.

Efficacy and safety of DPP-4 inhibitor in the treatment of patients with COVID-19 combined with diabetes mellitus: A protocol for systematic review and meta-analysis

Liu Y, Xie H, Gao H, Xie C.

Interplay between male testosterone levels and the risk for subsequent invasive respiratory assistance among COVID-19 patients at hospital admission

Salciccia S, Del Giudice F, Gentile V, Mastroianni CM, Pasculli P, Di Lascio G, Ciardi MR, Sperduti I, Maggi M, De Berardinis E, Eisenberg ML, Sciarra A.

Service restriction during the COVID-19 pandemic and its impact on HbA(1c) : a surprising outcome

Batten L, Chandrajay D, Burkinshaw C, Gill J, Jayagopal V.

Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study

Lampasona V, Secchi M, Scavini M, Bazzigaluppi E, Brigatti C, Marzinotto I, Davalli A, Caretto A, Laurenzi A, Martinenghi S, Molinari C, Vitali G, Di Filippo L, Mercalli A, Melzi R, Tresoldi C, Rovere-Querini P, Landoni G, Ciceri F, Bosi E, Piemonti L.

[Diabetes and hypertension as factors associated with Covid-19 lethality in Sonora, Mexico, 2020]

Álvarez-López DI, Espinoza-Molina MP, Cruz-Loustaunau ID, Álvarez-Hernández G.

Fatal case of COVID-19 in a 27-year-old woman with diabetes mellitus

Schlömmer C, Dünser MW, Antlanger M, Paar C, Winkler M, Meier J, Lamprecht B, Salzer HJF.

Lessons learned from the continuous glucose monitoring metrics in pediatric patients with type 1 diabetes under COVID-19 lockdown

Brener A, Mazor-Aronovitch K, Rachmiel M, Levek N, Barash G, Pinhas-Hamiel O, Lebenthal Y, Landau Z.

Risk factors for hospital admission among COVID-19 patients with diabetes. A study from Saudi Arabia

Al Hayek AA, Robert AA, Matar AB, Algarni A, Alkubedan H, Alharbi T, Al Amro A, Alrashidi SA, Al Dawish M.

Diabetic emergencies during the COVID-19 pandemic: a case-control study

Huda MSB, Shaho S, Trivedi B, Fraterrigo G, Chandrarajan L, Zolfaghari P, Dovey TM, Garrett CG, Chowdhury TA.

COVID-19: a cause of recurrent Graves' hyperthyroidism?

Jiménez-Blanco S, Pla-Peris B, Marazuela M.

Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis

Rotondi M, Coperchini F, Ricci G, Denegri M, Croce L, Ngnitejeu ST, Villani L, Magri F, Latrofa F, Chiovato L.

Expression of ACE2, the SARS-CoV-2 Receptor, in Lung Tissue of Patients With Type 2 Diabetes

Wijnant SR, Jacobs M, Van Eeckhoutte HP, Lapauw B, Joos GF, Bracke KR, Brusselle GG.

Impact of Comorbidities and Glycemia at Admission and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes With COVID-19: A Case Series From an Academic Hospital in Lombardy, Italy

Mirani M, Favacchio G, Carrone F, Betella N, Biamonte E, Morenghi E, Mazziotti G, Lania AG.

Increased paediatric presentations of severe diabetic ketoacidosis in an Australian tertiary centre during the COVID-19 pandemic

Lawrence C, Seckold R, Smart C, King BR, Howley P, Feltrin R, Smith TA, Roy R, Lopez P.

Behavioral changes in patients with diabetes during the COVID-19 pandemic

Kishimoto M, Ishikawa T, Odawara M.

Diabetes mellitus increases the risk of hospital mortality in patients with Covid-19: Systematic review with meta-analysis

Miller LE, Bhattacharyya R, Miller AL.

Alpha-lipoic acid may protect patients with diabetes against COVID-19 infection

Cure E, Cumhur Cure M.

Conventional PCR Assisted Single-Component Assembly of Spherical Nucleic Acids for Simple Colorimetric Detection of SARS-CoV-2

Karami A, Hasani M, Jalilian FA, Ezati R.

Lessons from COVID-19: how human behaviour may influence the science

Ceriello A.

SGLT-2 inhibitors as cardioprotective agents in COVID-19

Gupta K, Kunal S.

Diabetes, like COVID-19, is a wicked problem

Kerr D, Glantz N.

The Nutritional and Health Effects of the COVID-19 Pandemic on Patients with Diabetes Mellitus

Grabia M, Markiewicz-Żukowska R, Puścion-Jakubik A, Bielecka J, Nowakowski P, Gromkowska-Kępka K, Mielcarek K, Socha K.

Effect of increased BMI and obesity on the outcome of COVID-19 adult patients: A systematic review and meta-analysis

Soeroto AY, Soetedjo NN, Purwiga A, Santoso P, Kulsum ID, Suryadinata H, Ferdian F.

Being caught in the perfect storm of a diabetes epidemic and the COVID-19 pandemic: What should we do for our patients?

Cho Y, Yoon KH.

"The My Friend Diabetes Camp" was Held Online in Turkey This Year Due to the COVID-19 Pandemic

Hatun Ş, Yeşiltepe Mutlu G, Gökçe T, Can E, Muradoğlu S, Eviz E, Cemhan K.

A Novel Case of Hypoparathyroidism Secondary to SARS-CoV-2 Infection

Elkattawy S, Alyacoub R, Ayad S, Pandya M, Eckman A.

Subacute Thyroiditis Associated with COVID-19

Campos-Barrera E, Alvarez-Cisneros T, Davalos-Fuentes M.

Wisely choosing the numbers during the pandemic

Kambhampati SBS, Vaishya R.

Infections and diabetes: Risks and mitigation with reference to India

Unnikrishnan R, Misra A.

THE EFFECT OF COVID-19 ON RAMADAN FASTING IN PEOPLE WITH DIABETES IN EAST LONDON 2020: THE EAST LONDON DIABETES IN RAMADAN SURVEY

Khan H, Chowdhury A, Lasker SS, Chowdhury TA.

Diabetes and technology: a pilot study on the management of patients with insulin pumps during the COVID-19 pandemic

Petrelli F, Cangelosi G, Scuri S, Pantanetti P, Lavorgna F, Faldetta F, De Carolis C, Rocchi R, Debernardi G, Florescu A, Nittari G, Gamo Sagaro G, Garda G, Thu Nguyen CT, Grappasonni I.

COVID-19 and diabetes: the contributions of hyperglycemia

Wang J, Meng W.

Effect of coronavirus disease 2019 pandemic on the lifestyle and glycemic control in patients with type 2 diabetes: a cross-section and retrospective cohort study

Munekawa C, Hosomi Y, Hashimoto Y, Okamura T, Takahashi F, Kawano R, Nakajima H, Osaka T, Okada H, Majima S, Senmaru T, Nakanishi N, Ushigome E, Hamaguchi M, Yamazaki M, Fukui M.

Focus on uncommon symptoms of COVID-19: Potential reason for spread of infection

Pathak SK, Pandey S, Pandey A, Salunke AA, Thivari P, Ratna HVK, Chawla J.

The COVID-19 pandemic in developing countries: A new opportunity to improve the monitoring of patients with diabetes mellitus

Quispe Flores MA, Concepción Zavaleta MJ, Plasencia Dueñas EA, Kcomt Lam M.

Different Laboratory Abnormalities in COVID-19 Patients with Hypertension or Diabetes

Wu X, Wang T, Zhou Y, Liu X, Zhou H, Lu Y, Tan W, Yuan M, Ding X, Zou J, Li R, Liu H, Ewing RM, Hu Y, Nie H, Wang Y.

Menopause und COVID-19

Frigo P.

Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study

Solerte SB, D'Addio F, Trevisan R, Lovati E, Rossi A, Pastore I, Dell'Acqua M, Ippolito E, Scaranna C, Bellante R, Galliani S, Dodesini AR, Lepore G, Geni F, Fiorina RM, Catena E, Corsico A, Colombo R, Mirani M, De Riva C, Oleandri SE, Abdi R, Bonventre JV, Rusconi S, Folli F, Di Sabatino A, Zuccotti G, Galli M, Fiorina P.

Surveillance and re-Positive RNA test in Patients recovered from COVID-19

Hu J, Li S, Wu Y, Xiong Z, Yang Y, Gong L, Tian F.

Laboratory findings that predict a poor prognosis in COVID-19 patients with diabetes: A meta-analysis

Lagunas-Rangel FA, Chávez-Valencia V.

Type 1 diabetes and COVID-19: the "Lockdown effect"

Aragona M, Rodia C, Bertolotto A, Campi F, Coppelli A, Giannarelli R, Bianchi C, Dardano A, Del Prato S.

Continuous Glucose Monitors and Automated Insulin Dosing Systems in the Hospital Consensus Guideline

Galindo RJ, Umpierrez GE, Rushakoff RJ, Basu A, Lohnes S, Nichols JH, Spanakis EK, Espinoza J, Palermo NE, Awadjie DG, Bak L, Buckingham B, Cook CB, Freckmann G, Heinemann L, Hovorka R, Mathioudakis N, Newman T, O'Neal DN, Rickert M, Sacks DB, Seley JJ, Wallia A, Shang T, Zhang JY, Han J, Klonoff DC.

Diabetic Ketoacidosis Precipitated by COVID-19 in Patients Without Respiratory Symptoms: Case Reports

Meza JL, Triana A, De Avila I, Del Rio-Pertuz G, Viasus D.

The COVID-19 Effect on the Immune System and Mitochondrial Dynamics in Diabetes, Obesity, and Dementia

Holder K, Reddy PH.

Clinical characteristics and outcome of hospitalized COVID-19 patients with diabetes: A single-center, retrospective study in Iran

Akbariqomi M, Sadat Hosseini M, Rashidiani J, Sedighian H, Biganeh H, Heidari R, Moosazadeh Moghaddam M, Farnoosh G, Kooshki H.

Impacts of Type 2 Diabetes on Disease Severity, Therapeutic Effect, and Mortality of Patients With COVID-19

Wang X, Liu Z, Li J, Zhang J, Tian S, Lu S, Qi M, Ma J, Qiu B, Dong W, Xu Y.

Emotion analysis of Indians using google trends during COVID-19 pandemic

Rana U, Singh R.

Distant diabetes care: what can the patient, nurse and patient do

Saudek F, Picková K.

Diabetic ketoacidosis treatment during COVID-19 pandemic in a country with scarce health resources

Gutiérrez-Ortiz CC, Concepción-Zavaleta MJ, García-Villasante EJ.

Clinical characteristics of hospitalized and home isolated COVID-19 patients with type 1 diabetes

Al Hayek AA, Robert AA, Alotaibi ZK, Al Dawish M.

Clinical features of patients with type 2 diabetes with and without Covid-19: a case control study (CoViDiab I)

Maddaloni E, D'Onofrio L, Alessandri F, Mignogna C, Leto G, Coraggio L, Sterpetti S, Pascarella G, Mezzaroma I, Lichtner M, Pozzilli P, Eugenio Agrò F, Rocco M, Pugliese F, Maria Mastroianni C, Buzzetti R; CoViDiab Study group.

Characteristics of patients with diabetes hospitalised for COVID-19 infection-a brief case series report

Conway J, Gould A, Westley R, Raju S, Oklopcic A, Broadbent A, Abdelhafiz AH, Sinclair AJ.

INCIDENCE OF COVID-19 INFECTION AND PREVALENCE OF DIABETES, OBESITY AND HYPERTENSION ACCORDING TO ALTITUDE IN PERUVIAN POPULATION

Seclén SN, Nuñez-Robles E, Yovera-Aldana M, Arias Chumpitaz A.

Does glycemic control impact outcome of COVID-19?

Bloomgarden Z.

Positron Emission Tomography With Fluorodeoxyglucose Incidental Detection of Colon Cancer in a Patient's Follow-Up for Nasopharyngeal Carcinoma During the COVID-19 Pandemic: A Case Report

Basendowah M, Alshaynawi S, Madani TA, Alabdulqader MH, Hakami M.

COVID-19 pandemic: a double trouble for Indian adolescents and young adults living with type 1 diabetes

Agarwal N, Harikar M, Shukla R, Bajpai A.

PRESENTATION OF PAEDIATRIC TYPE 1 DIABETES IN MELBOURNE, AUSTRALIA DURING THE INITIAL STAGES OF THE COVID-19 PANDEMIC

Atlas G, Rodrigues F, Moshage Y, Welch J, White M, O'Connell MA.

Response to Comment on Chen et al. Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication. Diabetes Care 2020;43:1399-1407

Chen Y, Yang D, Yang C, Zheng L, Huang K.

Comment on Chen et al. Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication. Diabetes Care 2020;43:1399-1407

Cariou B, Hadjadj S, Wargny M, Pichelin M, Gourdy P.

Response to Comment on Cai et al. Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China. Diabetes Care 2020;43:1392-1398

Cai Q, Chen J, Xu L.

Comment on Cai et al. Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China. Diabetes Care 2020;43:1392-1398

He Z, Li J.

Preexisting prediabetes and the severity of COVID-19

Sathish T, Cao Y, Kapoor N.

Does a younger host make the virus weaker? Presenting a new hypothesis

Jayadevan R, Raveendran AV.

Effects of COVID-19 lockdown on type 2 diabetes, lifestyle and psychosocial health: A hospital-based cross-sectional survey from South India

Sankar P, Ahmed WN, Mariam Koshy V, Jacob R, Sasidharan S.

Effects of COVID-19 in South African health system and society: An explanatory study

Mbunge E.

Risk of metformin in type 2 diabetes patients with COVID-19: a preliminary retrospective report

Gao Y, Liu T, Zhong W, Liu R, Zhou H, Huang W, Zhang W.

Letter to the Editor: "COVID-19 and the endocrine system: exploring the unexplored". Focus on acromegaly

Mercuri V, D'Amico T, Gargiulo P.

Relationship between obesity, diabetes and ICU admission in COVID-19 patients

Fernández García L, Puentes Gutiérrez AB, García Bascones M.

Diabetic Ketoacidosis in Coronavirus Disease Patients With Type 2 Diabetes Mellitus

Winn SP, Oo ZT, Htun NN, Soe MHP, Aung MM.

Management of children and adolescents having type 1 diabetes during COVID-19 pandemic in India: challenges and solutions

Jethwani P, Saboo B, Jethwani L, Kesavadev J, Kalra S, Sahay R, Agarwal S, Hasnani D.

Diabetes and COVID-19: A pooled analysis related to disease severity and mortality

Varikasuvu SR, Dutt N, Thangappazham B, Varshney S.

Impact of COVID-19 and comorbidities on health and economics: Focus on developing countries and India

Singh AK, Misra A.

Managing gestational diabetes mellitus using a smartphone application with artificial intelligence (SineDie©) during the COVID-19 pandemic: Much more than just telemedicine

Albert L, Capel I, García-Sáez G, Martín-Redondo P, Elena Hernando M, Rigla M.

Markers of coagulation dysfunction and inflammation in diabetic and non-diabetic COVID-19

Varikasuvu SR, Varshney S, Dutt N.

Effect of COVID-19 lockdown on patients with chronic diseases

Saqib MAN, Siddiqui S, Qasim M, Jamil MA, Rafique I, Awan UA, Haroon M, Afzal MS.

Face masks are new normal after COVID-19 pandemic

Rab S, Javaid M, Haleem A, Vaishya R.

The immune-modulatory effects of exercise should be favorably harnessed against COVID-19

Codella R, Chirico A, Lucidi F, Ferrulli A, La Torre A, Luzi L.

Prevalence of Diabetes and Hypertension and Their Associated Risks for Poor Outcomes in Covid-19 Patients

Barrera FJ, Shekhar S, Wurth R, Moreno-Pena PJ, Ponce OJ, Hajdenberg M, Alvarez-Villalobos NA, Hall JE, Schiffrin EL, Eisenhofer G, Porter F, Brito JP, Bornstein SR, Stratakis CA, González-González JG, Rodíguez-Gutiérrez R, Hannah-Shmouni F.

Strategies to reduce severe diabetic foot infections and complications during epidemics (STRIDE)

Schmidt BM, Munson ME, Rothenberg GM, Holmes CM, Pop-Busui R.

Statin therapy did not improve the in-hospital outcome of coronavirus disease 2019 (COVID-19) infection

Hariyanto TI, Kurniawan A.

COVID-19, Diabetes and Ramadan

Chowdhury TA, Waqar S, Hussain S, Ahmed SH, Syed A, Karamat A, Helmy A, Ghouri N.

Mental health in the era of COVID-19: prevalence of psychiatric disorders in a cohort of patients with type 1 and type 2 diabetes during the social distancing

Alessi J, de Oliveira GB, Franco DW, Brino do Amaral B, Becker AS, Knijnik CP, Kobe GL, de Carvalho TR, Telo GH, Schaan BD, Telo GH.

Relation between blood glucose and the prognosis of severe coronavirus disease 2019

Liu Z, Liu S, Wang Z, Liu C, Long F, Jin P.

Imminent risk of COVID-19 in diabetes mellitus and undiagnosed diabetes mellitus patients

John JE, John NA.

Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: a meta-analysis

de Almeida-Pititto B, Dualib PM, Zajdenverg L, Dantas JR, de Souza FD, Rodacki M, Bertoluci MC; Brazilian Diabetes Society Study Group (SBD).

Increased mortality of COVID-19 infected diabetes patients: role of furin proteases

Ganesan SK, Venkatratnam P, Mahendra J, Devarajan N.

Efficacy and safety of ACEI/ARB drugs in patients with COVID-19 combined with diabetes mellitus: A protocol for systematic review and meta-analysis of randomized controlled trials

Yang Y, Liu X, Liu Y, Chen Y, Tian Y, Fu X, Zhong W, Xie C.

Diabetes mellitus is a risk factor for prolonged SARS-CoV-2 viral shedding in lower respiratory tract samples of critically ill patients

Buetti N, Trimboli P, Mazzuchelli T, Lo Priore E, Balmelli C, Trkola A, Conti M, Martinetti G, Elzi L, Ceschi A, Consonni V, Ogna A, Forni-Ogna V, Bernasconi E.

Retinal findings in COVID-19 patients with diabetes mellitus

Guemes-Villahoz N, Burgos-Blasco B, Donate López J, García-Feijoó J.

The COVID-19 pandemic substantially complicates the usual challenges for patients with diabetes in Latin America

Arredondo A.

Is diabetes mellitus a risk factor for COronaVIrus Disease 19 (COVID-19)?

Pugliese G, Vitale M, Resi V, Orsi E.

COVID-19 and diabetes cutaneous comorbidity

Zhang M, Gao W.

Reply to "Comment on androgenetic alopecia present in the majority of patients hospitalized with COVID-19"

Wambier CG.

Comment on "Androgenetic alopecia present in the majority of patients hospitalized with COVID-19"

Bukovac D, Makše U.

Controlled obesity status: a rarely used concept, but with particular importance in the COVID-19 pandemic and beyond

Halpern B, Mancini MC.

A cross sectional study reveals severe disruption in glycemic control in people with diabetes during and after lockdown in India

Khader MA, Jabeen T, Namoju R.

Response: The Risk of Diabetes on Clinical Outcomes in Patients with Coronavirus Disease 2019: A Retrospective Cohort Study (Diabetes Metab J 2020;44:405-13)

Chung SM, Ahn JH, Moon JS.

Letter: The Risk of Diabetes on Clinical Outcomes in Patients with Coronavirus Disease 2019: A Retrospective Cohort Study (Diabetes Metab J 2020;44:405-13)

Kim SY, Kim KS.

Hyperglycemia and COVID-19: What was known and what is really new?

Ceriello A.

"Diabetes as a case study of chronic disease management": eight years later. The opportunity learned from the COVID-19 pandemic

Ceriello A.

J-shaped Association Between Fasting Blood Glucose Levels and COVID-19 Severity in Patients without Diabetes

Zhu B, Jin S, Wu L, Hu C, Wang Z, Bu L, Sun H, Wang X, Qu S, Chen D.

Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19

Singh AK, Singh R.

The association of diabetes and the prognosis of COVID-19 patients: a retrospective study

Liu Z, Bai X, Han X, Jiang W, Qiu L, Chen S, Yu X.

High body mass index and night shift work are associated with COVID-19 in health care workers

Rizza S, Coppeta L, Grelli S, Ferrazza G, Chiocchi M, Vanni G, Bonomo OC, Bellia A, Andreoni M, Magrini A, Federici M.

Clinical Characteristics of Diabetic Patients with COVID-19

Li G, Deng Q, Feng J, Li F, Xiong N, He Q.

Quarantine Due to the COVID-19 Pandemic From the Perspective of Pediatric Patients With Type 1 Diabetes: A Web-Based Survey

Passanisi S, Pecoraro M, Pira F, Alibrandi A, Donia V, Lonia P, Pajno GB, Salzano G, Lombardo F.

DPP-4 Inhibitors in the Prevention/Treatment of Pulmonary Fibrosis, Heart and Kidney Injury Caused by COVID-19-A Therapeutic Approach of Choice in Type 2 Diabetic Patients?

Smelcerovic A, Kocic G, Gajic M, Tomovic K, Djordjevic V, Stankovic-Djordjevic D, Anderluh M.

DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?

Valencia I, Peiró C, Lorenzo Ó, Sánchez-Ferrer CF, Eckel J, Romacho T.

Fasting Plasma Glucose Level Independently Predicts the Mortality of Patients with Coronavirus Disease 2019 Infection: A Multicenter, Retrospective Cohort Study

Chang MC, Hwang JM, Jeon JH, Kwak SG, Park D, Moon JS.

The COVID-19 pandemic and diabetes mellitus

Papazafiropoulou AK, Antonopoulos S.

Molecular docking analysis of Withaferin A from Withania somnifera with the Glucose regulated protein 78 (GRP78) receptor and the SARS-CoV-2 main protease

Sudeep HV, Gouthamchandra K, Shyamprasad K.

Caring for children and adolescents with type 1 diabetes mellitus: italian society for pediatric and adolescent diabetes (ISPED) Statements during COVID-19 pandemia

d'Annunzio G, Maffeis C, Cherubini V, Rabbone I, Scaramuzza A, Schiaffini R, Minuto N, Piccolo G, Maghnie M.

Did the COVID-19 Lockdown Affect the Incidence of Pediatric Type 1 Diabetes in Germany?

Tittel SR, Rosenbauer J, Kamrath C, Ziegler J, Reschke F, Hammersen J, Mönkemöller K, Pappa A, Kapellen T, Holl RW; DPV Initiative.

A multistage combined approach to promote diabetic wound healing in COVID-19 era

Grande R, Fiori G, Russo G, Fioramonti P, Campagnol M, di Marzo L.

Diabetes and Covid-19: An interplay difficult to dissect

Napoli R.

New-Onset Type 1 Diabetes in Children During COVID-19: Multicenter Regional Findings in the U.K

Unsworth R, Wallace S, Oliver NS, Yeung S, Kshirsagar A, Naidu H, Kwong RMW, Kumar P, Logan KM.

Monocytopenia, monocyte morphological anomalies and hyperinflammation characterise severe COVID-19 in type 2 diabetes

Alzaid F, Julla JB, Diedisheim M, Potier C, Potier L, Velho G, Gaborit B, Manivet P, Germain S, Vidal-Trecan T, Roussel R, Riveline JP, Dalmas E, Venteclef N, Gautier JF.

Blood glucose levels and COVID-19. Reply to Sardu C, D'Onofrio N, Balestrieri ML et al [letter] and Lepper PM, Bals R, Jüni P et al [letter]

Cariou B, Hadjadj S, Wargny M, Pichelin M, Al-Salameh A, Allix I, Amadou C, Arnault G, Baudoux F, Bauduceau B, Borot S, Bourgeon-Ghittori M, Bourron O, Boutoille D, Cazenave-Roblot F, Chaumeil C, Cosson E, Coudol S, Darmon P, Disse E, Ducet-Boiffard A, Gaborit B, Joubert M, Kerlan V, Laviolle B, Marchand L, Meyer L, Potier L, Prevost G, Riveline JP, Robert R, Saulnier PJ, Sultan A, Thébaut JF, Thivolet C, Tramunt B, Vatier C, Roussel R, Gautier JF, Gourdy P; CORONADO investigators.

Diabetes Mellitus is Associated with Severe Infection and Mortality in Patients with COVID-19: A Systematic Review and Meta-analysis

Shang L, Shao M, Guo Q, Shi J, Zhao Y, Xiaokereti J, Tang B.

COVID-19 and diabetes: Covidiabetology

Kalra S, Mittal S.

Severe diabetic ketoacidosis and coronavirus disease 2019 (COVID-19) infection in a teenage patient with newly diagnosed diabetes

Rabizadeh S, Hajmiri M, Rajab A, Emadi Kouchak H, Nakhjavani M.

Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration

Paolo Fadini G, Luca Morieri M, Boscari F, Fioretto P, Maran A, Busetto L, Maria Bonora B, Selmin E, Arcidiacono G, Pinelli S, Farnia F, Falaguasta D, Russo L, Voltan G, Mazzocut S, Costantini G, Ghirardini F, Tresso S, Maria Cattelan A, Vianello A, Avogaro A, Vettor R.

Fast-track pathway for diabetic foot ulceration during COVID-19 crisis: a document from International Diabetic Foot Care Group and D-Foot International

Meloni M, Bouillet B, Ahluwalia R, Lüdemann C, Sánchez-Ríos JP, Iacopi E, Lazaro Martinez JL.

The relationship between diabetes and clinical outcomes in COVID-19: a single-center retrospective analysis

Fox T, Ruddiman K, Lo KB, Peterson E, DeJoy R 3rd, Salacup G, Pelayo J, Bhargav R, Gul F, Albano J, Azmaiparashvili Z, Anastasopoulou C, Patarroyo-Aponte G.

Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet)

Panzuto F, Maccauro M, Campana D, Faggiano A, Massironi S, Pusceddu S, Spada F, Ferone D, Modica R, Grana CM, Ferolla P, Rinzivillo M, Badalamenti G, Zatelli MC, Gelsomino F, De Carlo E, Bartolomei M, Brizzi MP, Cingarlini S, Versari A, Fanciulli G, Arvat E, Merola E, Cives M, Tafuto S, Baldari S, Falconi M.

Hypertension and diabetes mellitus in patients with COVID 19: a viewpoint on mortality

Tascioglu D, Yalta K, Yetkin E.

Are people with uncontrolled diabetes mellitus at high risk of reinfections with COVID-19?

Pal R, Banerjee M.

Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study

Barron E, Bakhai C, Kar P, Weaver A, Bradley D, Ismail H, Knighton P, Holman N, Khunti K, Sattar N, Wareham NJ, Young B, Valabhji J.

Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study

Holman N, Knighton P, Kar P, O'Keefe J, Curley M, Weaver A, Barron E, Bakhai C, Khunti K, Wareham NJ, Sattar N, Young B, Valabhji J.

Bridging the Needs of Adolescent Diabetes Care During Coronavirus Disease 2019: A Nurse-Led Telehealth Initiative

Lim ST, Yap F, Chin X.

Tackling Obesity During the COVID-19 Pandemic

Akirov A, Cahn A, Del Prato S, Home P, Van Gaal L, Chan J, Ning G, Raz I; Global CODHY Expert Forum.

Diabetes care during COVID 19: Experience in telemedicine from a developing country

García-Villasante E, Baca-Carrasco V, Gutierrez-Ortiz C, Pinedo-Torres I.

A proposed ABCD scoring system for patient's self assessment and at emergency department with symptoms of COVID-19

Salunke AA, Pathak SK, Dhanwate A, Warikoo V, Nandy K, Mendhe H, Kottakota V, Shinde RM, Patil SA, Petiwala T, Pandya S.

A Diabetes and COVID-19 Dilemma: Balancing Parents' Health & Children's Education

Mehta PB, Rushakoff RJ.

The Clinical Characteristics and Outcomes of Patients with Moderate-to-Severe Coronavirus Disease 2019 Infection and Diabetes in Daegu, South Korea

Kim MK, Jeon JH, Kim SW, Moon JS, Cho NH, Han E, You JH, Lee JY, Hyun M, Park JS, Kwon YS, Choi YK, Kwon KT, Lee SY, Jeon EJ, Kim JW, Hong HL, Kwon HH, Jung CY, Lee YY, Ha E, Chung SM, Hur J, Ahn JH, Kim NY, Kim SW, Chang HH, Lee YH, Lee J, Park KG, Kim HA, Lee JH.

Children's Anxiety and Physical Activity during COVID-19 in Relation to Prenatal Exposure to Gestational Diabetes

Alves J, Yunker AG, DeFendis A, Xiang AH, Page KA.

COVID-19, ketoacidosis, and new-onset Diabetes: might we envisage any cause-effect relationships among them?

Gentile S, Strollo F, Mambro A, Ceriello A.

Potentially modifiable factors to reduce severity of COVID-19 in type 2 diabetes

Dhurandhar NV, Akheruzzaman M, Hegde V.

Expression Profile of SARS-CoV-2 Host Receptors in Human Pancreatic Islets Revealed Upregulation of ACE2 in Diabetic Donors

Taneera J, El-Huneidi W, Hamad M, Mohammed AK, Elaraby E, Hachim MY.

Hospital Diabetes Meeting 2020

Umpierrez G, Rushakoff R, Seley JJ, Zhang JY, Shang T, Han J, Spanakis EK, Alexanian S, Drincic A, Kulasa K, Mendez CE, Tanton D, Wallia A, Zilbermint M, Klonoff DC.

Is subacute thyroiditis an underestimated manifestation of SARS-CoV-2 infection? Insights from a case series

Brancatella A, Ricci D, Cappellani D, Viola N, Sgrò D, Santini F, Latrofa F.

A Territory-wide Study on the Impact of COVID-19 on Diabetes-Related Acute Care

Lui DTW, Lee CH, Chow WS, Fong CHY, Woo YC, Lam KSL, Tan KCB.

Hypothesized mechanisms explaining poor prognosis in type 2 diabetes patients with COVID-19: a review

Lisco G, De Tullio A, Giagulli VA, Guastamacchia E, De Pergola G, Triggiani V.

Managing Hyperglycemia in the COVID-19 Inflammatory Storm

Gianchandani R, Esfandiari NH, Ang L, Iyengar J, Knotts S, Choksi P, Pop-Busui R.

Has COVID-19 Delayed the Diagnosis and Worsened the Presentation of Type 1 Diabetes in Children?

Rabbone I, Schiaffini R, Cherubini V, Maffeis C, Scaramuzza A; Diabetes Study Group of the Italian Society for Pediatric Endocrinology and Diabetes*; Diabetes Study Group of the Italian Society for Pediatric Endocrinology and Diabetes.

COVID-19 and steroid therapy: Impact on diabetes

Mittal S, Madan K, Mohan A.

Impact of diabetes on COVID-19-related in-hospital mortality: a retrospective study from Northern Italy

Ciardullo S, Zerbini F, Perra S, Muraca E, Cannistraci R, Lauriola M, Grosso P, Lattuada G, Ippoliti G, Mortara A, Manzoni G, Perseghin G.

Postoperative vocal fold dysfunction in covid-19 era: are we still in time for a recovery?

Bonati E, Bignami EG, Del Rio P.

Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19

Carpagnano GE, Di Lecce V, Quaranta VN, Zito A, Buonamico E, Capozza E, Palumbo A, Di Gioia G, Valerio VN, Resta O.

Prediction of new active cases of coronavirus disease (COVID-19) pandemic using multiple linear regression model

Rath S, Tripathy A, Tripathy AR.

Dyslipidemia is associated with severe coronavirus disease 2019 (COVID-19) infection

Hariyanto TI, Kurniawan A.

Diabetic ketoacidosis precipitated by COVID-19: A report of two cases and review of literature

Reddy PK, Kuchay MS, Mehta Y, Mishra SK.

Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection who have no comorbidities like diabetes mellitus: A structured summary of a study protocol for a r

Akram J, Azhar S, Shahzad M, Latif W, Khan KS.

Intervention Delivery Matters: What Mothers at High Risk for Type 2 Diabetes Want in a Diabetes Prevention Program-Results from a Comparative Effectiveness Trial

Palmer KNB, Garr Barry VE, Marrero DG, McKinney BM, Graves AN, Winters CK, Hannon TS.

Feasibility of Inpatient Continuous Glucose Monitoring During the COVID-19 Pandemic: Early Experience

Reutrakul S, Genco M, Salinas H, Sargis RM, Paul C, Eisenberg Y, Fang J, Caskey RN, Henkle S, Fatoorehchi S, Osta A, Srivastava P, Johnson A, Messmer SE, Barnes M, Pratuangtham S, Layden BT.

Preadmission Diabetes-Specific Risk Factors for Mortality in Hospitalized Patients With Diabetes and Coronavirus Disease 2019

Agarwal S, Schechter C, Southern W, Crandall JP, Tomer Y.

Characteristics and Diabetes Control in Adults With Type 1 Diabetes Admitted With COVID-19 Infection

Vamvini M, Lioutas VA, Middelbeek RJW.

The COVID-19 Outbreak Negatively Affects the Delivery of Care for Patients With Diabetic Foot Ulcers

Liu C, You J, Zhu W, Chen Y, Li S, Zhu Y, Ji S, Wang Y, Li H, Li L, Fan S.

ACE polymorphism and COVID-19 outcome

Delanghe JR, Speeckaert MM, De Buyzere ML.

The association of hypertension and diabetes pharmacotherapy with COVID-19 severity and immune signatures: an observational study

Dalan R, Ang LW, Tan WYT, Fong SW, Tay WC, Chan YH, Renia L, Ng LFP, Lye DC, Chew DEK, Young BE.

METFORMIN USE IS ASSOCIATED WITH REDUCED MORTALITY IN A DIVERSE POPULATION WITH COVID-19 AND DIABETES

Crouse A, Grimes T, Li P, Might M, Ovalle F, Shalev A.

A Case of Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State in a Patient With COVID-19

Rafique S, Ahmed FW.

Diabetes and COVID-19 risk: a miRNA perspective

Mishra PK, Tandon R, Byrareddy SN.

Rapid Implementation of a Diabetes Telemedicine Clinic During the Coronavirus Disease 2019 Outbreak: Our Protocol, Experience, and Satisfaction Reports in Saudi Arabia

Al-Sofiani ME, Alyusuf EY, Alharthi S, Alguwaihes AM, Al-Khalifah R, Alfadda A.

COVID-19 and Diabetes: What Should We Expect?

Pedrosa MDS, Neves Nogueira F.

Diabetes in the Time of COVID-19: A Twitter-Based Sentiment Analysis

Cignarelli A, Sansone A, Caruso I, Perrini S, Natalicchio A, Laviola L, Jannini EA, Giorgino F.

COVID-19 and Diabetes: The Importance of Controlling RAGE

De Francesco EM, Vella V, Belfiore A.

Association Between Diabetes and COVID-19: A Retrospective Observational Study With a Large Sample of 1,880 Cases in Leishenshan Hospital, Wuhan

Liu Z, Li J, Huang J, Guo L, Gao R, Luo K, Zeng G, Zhang T, Yi M, Huang Y, Chen J, Yang Y, Wu X.

COVID-19 Lockdown and Changes of the Dietary Pattern and Physical Activity Habits in a Cohort of Patients with Type 2 Diabetes Mellitus

Ruiz-Roso MB, Knott-Torcal C, Matilla-Escalante DC, Garcimartín A, Sampedro-Nuñez MA, Dávalos A, Marazuela M.

Role of comorbidities like diabetes on severe acute respiratory syndrome coronavirus-2: A review

Das S, Anu KR, Birangal SR, Nikam AN, Pandey A, Mutalik S, Joseph A.

Avoiding COVID-19 complications with diabetic patients could be achieved by multi-dose Bacillus Calmette-Guérin vaccine: a case study of beta cells regeneration

Ayoub BM, Ramadan E, Ashoush N, Tadros MM, Hendy MS, Elmazar MM, Mousa SA.

Diabetic retinopathy screening and the COVID-19 pandemic in Brazil

Malerbi FK, Morales PHA, Regatieri CVS.

MECHANISMS IN ENDOCRINOLOGY: Vitamin D and COVID-19

Bilezikian JP, Bikle D, Hewison M, Lazaretti-Castro M, Formenti AM, Gupta A, Madhavan MV, Nair N, Babalyan V, Hutchings NJ, Napoli N, Accili D, Binkley N, Landry DW, Giustina A.

Fighting infodemic: Need for robust health journalism in India

Sharma DC, Pathak A, Chaurasia RN, Joshi D, Singh RK, Mishra VN.

Tuberculosis in the era of COVID-19 in India

Jain VK, Iyengar KP, Samy DA, Vaishya R.

Impact of COVID -19 in cancer patients on severity of disease and fatal outcomes: A systematic review and meta-analysis

Salunke AA, Nandy K, Pathak SK, Shah J, Kamani M, Kottakota V, Thivari P, Pandey A, Patel K, Rathod P, Bhatt S, Dave P, Pandya S.

Thyroid disease is associated with severe coronavirus disease 2019 (COVID-19) infection

Hariyanto TI, Kurniawan A.

ARIMA modelling & forecasting of COVID-19 in top five affected countries

Sahai AK, Rath N, Sood V, Singh MP.

"Compliance of the Indian National Task Force guidelines for COVID-19 recommendation by Indian doctors - A survey"

Gangopadhyay KK, Sinha B, Ghosal S.

Commentary on "angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic"

Ferrario CM.

Is it the COVID-19 happy hypoxia syndrome or the COVID 19 infodemic syndrome?

Sahu D, Agrawal T.

Executive dysfunction in COVID-19 patients

Ardila A, Lahiri D.

Vaccine development against coronavirus (2003 to present): An overview, recent advances, current scenario, opportunities and challenges

Badgujar KC, Badgujar VC, Badgujar SB.

SARS-CoV-2-host dynamics: Increased risk of adverse outcomes of COVID-19 in obesity

Yadav R, Aggarwal S, Singh A.

Reverse quarantine and COVID-19

Raveendran AV, Jayadevan R.

Corrigendum to "Vitamin D concentrations and COVID-19 infection in UK Biobank" [Diabetes Metabol Syndr: Clin Res Rev 2020 14 (4) 561-5]

Hastie CE, Mackay DF, Ho F, Celis-Morales CA, Katikireddi SV, Niedzwiedz CL, Jani BD, Welsh P, Mair FS, Gray SR, O'Donnell CA, Gill JM, Sattar N, Pell JP.

Applications of industry 4.0 to overcome the COVID-19 operational challenges

Kumar MS, Raut DRD, Narwane DVS, Narkhede DBE.

Retraction of: No Deleterious Effect of Lockdown Due to COVID-19 Pandemic on Glycaemic Control, Measured by Glucose Monitoring, in Adults with Type 1 Diabetes. Beato-Vibora PI. Diabetes Technol Ther 2020; epub DOI: 10.1089/dia.2020.0184

Thyroid cancer in the Era of COVID-19

Smulever A, Abelleira E, Bueno F, Pitoia F.

COVID-19 Pneumonia: An Emerging Cause of Syndrome of Inappropriate Antidiuretic Hormone

Sheikh MM, Ahmad E, Jeelani HM, Riaz A, Muneeb A.

Impaired Fasting Glucose and Diabetes Are Related to Higher Risks of Complications and Mortality Among Patients With Coronavirus Disease 2019

Zhang J, Kong W, Xia P, Xu Y, Li L, Li Q, Yang L, Wei Q, Wang H, Li H, Zheng J, Sun H, Xia W, Liu G, Zhong X, Qiu K, Li Y, Wang H, Wang Y, Song X, Liu H, Xiong S, Liu Y, Cui Z, Hu Y, Chen L, Pan A, Zeng T.

Diabetes and COVID-19: Moving From News to Knowledge and a Glucose Hypothesis

Riddle MC.

Increased Hepatic ACE2 Expression in NAFL and Diabetes-A Risk for COVID-19 Patients?

Soldo J, Heni M, Königsrainer A, Häring HU, Birkenfeld AL, Peter A.

Sex Hormones and Novel Corona Virus Infectious Disease (COVID-19)

Al-Lami RA, Urban RJ, Volpi E, Algburi AMA, Baillargeon J.

Approaches to screening for hyperglycaemia in pregnant women during and after the COVID-19 pandemic

Meek CL, Lindsay RS, Scott EM, Aiken CE, Myers J, Reynolds R, Simmons D, Yamamoto JM, McCance DR, Murphy HR.

Knowledge levels among elderly people with Diabetes Mellitus concerning COVID-19: an educational intervention via a teleservice

de Lima Filho BF, Bessa NPOS, Fernandes ACT, da Silva Patrício ÍF, de Oliveira Alves N, da Costa Cavalcanti FA.

Diabetic retinopathy screening in urban primary care setting with a handheld smartphone-based retinal camera

Queiroz MS, de Carvalho JX, Bortoto SF, de Matos MR, das Graças Dias Cavalcante C, Andrade EAS, Correa-Giannella ML, Malerbi FK.

[COVID-19 and fragility hip fracture. Joint recommendations of the Spanish Society of Osteoporotic Fractures and the Spanish Society of Geriatrics and Gerontology]

Caeiro-Rey JR, Ojeda-Thies C, Cassinello-Ogea C, Sáez-López MP, Etxebarría-Foronda Í, Pareja-Sierra T, Larrainzar-Garijo R, Figueroa-Rodríguez J, Freire Romero A, Sende-Munin N, Del Río-Pombo E, Carro-Méndez B, Mesa-Ramos M, González-Macías J, Tarazona-Santabalbina FJ.

Management changes for patients with endocrine-related cancers in the COVID-19 pandemic

Raghavan D, Tan AR, Story ES, Burgess EF, Musselwhite L, Kim ES, Clark PE.

COVID-19 and diabetes mellitus: how one pandemic worsens the other

Azar WS, Njeim R, Fares AH, Azar NS, Azar ST, El Sayed M, Eid AA.

Why diabetes must not be forgotten in the global fight against COVID-19

Boulton A.

Assessment of the effect of the COVID-19 lockdown on glycaemic control in people with type 1 diabetes using flash glucose monitoring

Dover AR, Ritchie SA, McKnight JA, Strachan MWJ, Zammitt NN, Wake D, Forbes S, Stimson RH, Gibb FW.

Dexamethasone therapy in COVID-19 patients: implications and guidance for the management of blood glucose in people with and without diabetes

Rayman G, Lumb AN, Kennon B, Cottrell C, Nagi D, Page E, Voigt D, Courtney HC, Atkins H, Platts J, Higgins K, Dhatariya K, Patel M, Narendran P, Kar P, Newland-Jones P, Stewart R, Burr O, Thomas S.

Testing for gestational diabetes during the COVID-19 pandemic. An evaluation of proposed protocols for the United Kingdom, Canada and Australia

David McIntyre H, Gibbons KS, C W Ma R, Hung Tam W, Sacks DA, Lowe J, Madsen LR, Catalano PM.

The impact of strict COVID-19 lockdown in Spain on glycemic profiles in patients with type 1 Diabetes prone to hypoglycemia using standalone continuous glucose monitoring

Mesa A, Viñals C, Pueyo I 1st, Roca D, Vidal M, Giménez M, Conget I.

Euglycaemic ketoacidosis during gestational diabetes with concomitant COVID-19 infection

Smati S, Moreau PM, Bourdiol A, Ploteau S, Hadjadj S, Cariou B.

Bilateral adrenal hemorrhage in Coronavirus disease 2019 patient: A case report

Frankel M, Feldman I, Levine M, Frank Y, Bogot NR, Benjaminov O, Kurd R, Breuer GS, Munter G.

Inpatient Diabetes and Hyperglycemia Management Protocol in the COVID-19 Era

Aljehani FA, Funke K, Hermayer KL.

Androgenetic alopecia in COVID-19: compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign

Wambier CG, Vaño-Galván S, McCoy J, Pai S, Dhurat R, Goren A.

Androgenetic alopecia in COVID-19: Compared to what?

Nanes BA.

[The endocrine and metabolic link between COVID-19, diabetes and obesity]

Weis N, Thorsteinsson K, Martinussen C, Madsbad S.

Is blood glucose or obesity responsible for the bad prognosis of COVID-19 in obesity -diabetes?

Pontiroli AE, La Sala L, Chiumello D, Folli F.

Estradiol, progesterone, immunomodulation and COVID-19 outcomes

Mauvais-Jarvis F, Klein SL, Levin ER.

Prescription rates of cardiovascular and diabetes therapies prior to and during the COVID-19 lockdown in Germany‚Ä©

Kostev K, Kumar S, Konrad M, Bohlken J.

Clinical Characteristics and Outcomes of Coronavirus Disease 2019 Infections among Diabetics: a Retrospective and Multicenter Study in China

Yi H, Lu F, Jin X, Chen R, Liu B, Dong X, Xiong W, Yang D, Guo Y, Zhou M.

Heightened ACE Activity and Unfavorable Consequences in COVID-19 Diabetic Subjects

Sandooja R, Vura NVRK, Morocco M.

Endothelial activation and dysfunction in metabolic syndrome, type 2 diabetes and coronavirus disease 2019

Hayden MR.

Inflammation: A bridge between diabetes and COVID-19, and possible management with sitagliptin

Mozafari N, Azadi S, Mehdi-Alamdarlou S, Ashrafi H, Azadi A.

Virtual Consultations: Considerations for the Role of Technology During the Covid-19 Pandemic for People With Type Two Diabetes-UK Perspective

Quinn LM, Davies MJ, Hadjiconstantinou M.

Delineating clinical characteristics and comorbidities among 206 COVID-19deceasedpatients in India: Emerging significance of renin angiotensin system derangement

Majeed J, Ajmera P, Goyal RK.

Hyperglycemia is a strong predictor of poor prognosis in COVID-19

Liu SP, Zhang Q, Wang W, Zhang M, Liu C, Xiao X, Liu Z, Hu WM, Jin P.

More Studies are Needed on the Link between Metformin and Decreased Mortality in Diabetic COVID-19 Patients

Fysekidis M, Cohen R, Al-Salameh A.

Diabetes and COVID-19: A systematic review on the current evidences

Abdi A, Jalilian M, Ahmadi Sarbarzeh P, Vlaisavljevic Z.

The COVID19 Pandemic - Perspectives from People Living with Diabetes

Kyle Jacques R, Renza S.

Characteristics of laboratory findings of COVID-19 patients with comorbid diabetes mellitus

Jing Liang J, Liu J, Chen Y, Ye B, Li N, Wang X, Tang M, Shao J.

Impact of covid-19 lockdown on glycemic control in patients with type 1 diabetes

Fern√°ndez E, Cortazar A, Bellido V.

Recommendations and management of hyperglycaemia in pregnancy during COVID-19 pandemic in Italy

Torlone E, Angela Sculli M, Bonomo M, Di Benedetto A, Di Cianni G, Festa C, Formoso G, Lapolla A, Mannino D, Napoli A, Scavini M, Succurro E, Vitacolonna E, Sciacca L.

Comorbid diabetes and the risk of disease severity or death among 8807 COVID-19 patients in China: a meta-analysis

Guo L, Shi Z, Zhang Y, Wang C, Cristina Do Vale Moreira N, Zuo H, Hussain A.

Knowledge, attitudes and practices towards COVID-19 among young adults with Type 1 Diabetes Mellitus amid the nationwide lockdown in India: A cross-sectional survey

Pal R, Yadav U, Grover S, Saboo B, Verma A, Bhadada SK.

Perceived Risk, Behavior Changes and Health-related Outcomes During COVID-19 Pandemic: Findingsamong Adults with and without Diabetesin China

Yan AF, Sun X, Zheng J, Mi B, Zuo H, Ruan G, Hussain A, Wang Y, Shi Z.

A 65-Year-Old Woman with a History of Type 2 Diabetes Mellitus and Hypertension and a 15-Day History of Dry Cough and Fever Who Presented with Acute Renal Failure Due to Infection with SARS-Cov-2

Sánchez Tinajero Á, González Cueto E, Martínez Orozco JA, Becerril Vargas E, Ruiz Santillán DP, Reséndiz Escobar H.

COVID-19 Pandemic-Related Practices and Policies Affecting the Continuity of Behavioral Health Care Among Children With Diabetes

Clary L, Wang C, Byrne ME, Monaghan M.

Clinical Management of Diabetes Mellitus in the Era of COVID-19: Practical Issues, Peculiarities and Concerns

Koliaki C, Tentolouris A, Eleftheriadou I, Melidonis A, Dimitriadis G, Tentolouris N.

Analysis of the lymphocyte count in type 2 diabetic patients with coronavirus disease (COVID-19): A retrospective study in a centralized treatment center

Wu D, Gao S.

Lymphocyte subsets with the lowest decline at baselineand the slow lowest rise during recovery in COVID-19 critical illnesspatients with diabetes mellitus

Liu D, Lan L, Luo D, Zhao B, Wei G, He Y, Zhang R, Liu Y.

COVID-19 and Diabetes: International Diabetes Federation Perspectives

Hussain A, Jm Boulton A.

Management of diabetes in patients with COVID-19 - Authors' reply

Bornstein SR, Zimmet P, Rubino F, Ludwig B.

Management of diabetes in patients with COVID-19

Khalangot M.

Management of diabetes in patients with COVID-19

Li A, Harris S, Kariyawasam D, Patel DC, Thomas SM.

Management of diabetes in patients with COVID-19

Munshi MN, Sy SL.

Management of diabetes in patients with COVID-19

Mukherjee JJ, Gangopadhyay KK, Ray S.

Management of diabetes in patients with COVID-19

Lalau JD, Al-Salameh A.

Newly diagnosed diabetes mellitus, DKA and COVID-19: causality or coincidence? - A report of 3 cases

Suwanwongse K, Shabarek N.

Mechanism of higher risk for COVID-19 in diabetes: a mask to lift

Fang C, Huang Y, Guo H, Sun Y, Li H, Bian X, Guan H, Hu J.

Diabetic Foot Problems During the COVID-19 Pandemic in a Tertiary Care Center: The Emergency Among the Emergencies

Caruso P, Longo M, Signoriello S, Gicchino M, Maiorino MI, Bellastella G, Chiodini P, Giugliano D, Esposito K.

Ketoacidosis in Children and Adolescents With Newly Diagnosed Type 1 Diabetes During the COVID-19 Pandemic in Germany

Kamrath C, Mönkemöller K, Biester T, Rohrer TR, Warncke K, Hammersen J, Holl RW.

Endocrine disrupting chemicals and COVID-19 relationships: a computational systems biology approach

Wu Q, Coumoul X, Grandjean P, Barouki R, Audouze K.

SARS-CoV-2: the endocrinological protective clinical model derived from patients with prostate cancer

La Vignera S, Cannarella R, Condorelli RA, Torre F, Aversa A, Calogero AE.

COVID-19 and Diabetes

Brunton SA, Williams N.

Treating type 2 diabetes in COVID-19 patients: the potential benefits of injective therapies

Longo M, Caruso P, Maiorino MI, Bellastella G, Giugliano D, Esposito K.